geneId,Gene,DSI,DPI,diseaseId,diseaseName,diseaseType,diseaseClass,diseaseSemanticType,score,EI,YearInitial,YearFinal,NofPmids,NofSnps,source
20,ABCA2,0.67,0.615,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
22,ABCB7,0.678,0.385,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2019,2019,1,0,BEFREE
24,ABCA4,0.493,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
31,ACACA,0.48,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
47,ACLY,0.563,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
47,ACLY,0.563,0.692,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
47,ACLY,0.563,0.692,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
47,ACLY,0.563,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
60,ACTB,0.325,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
60,ACTB,0.325,0.923,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
60,ACTB,0.325,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
60,ACTB,0.325,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
60,ACTB,0.325,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
60,ACTB,0.325,0.923,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
90,ACVR1,0.535,0.731,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2014,2014,3,0,CTD_human
90,ACVR1,0.535,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
103,ADAR,0.501,0.808,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
117,ADCYAP1R1,0.561,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
117,ADCYAP1R1,0.561,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
126,ADH1C,0.547,0.731,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
133,ADM,0.436,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
133,ADM,0.436,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
142,PARP1,0.389,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
153,ADRB1,0.555,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
154,ADRB2,0.442,0.923,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
155,ADRB3,0.533,0.731,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
155,ADRB3,0.533,0.731,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
155,ADRB3,0.533,0.731,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
174,AFP,0.429,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
174,AFP,0.429,0.885,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
177,AGER,0.42,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
181,AGRP,0.488,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
199,AIF1,0.521,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
207,AKT1,0.311,0.962,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
207,AKT1,0.311,0.962,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
207,AKT1,0.311,0.962,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
207,AKT1,0.311,0.962,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
207,AKT1,0.311,0.962,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
207,AKT1,0.311,0.962,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
207,AKT1,0.311,0.962,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
207,AKT1,0.311,0.962,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2014,2017,2,0,BEFREE
207,AKT1,0.311,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.04,1,2011,2019,4,0,BEFREE
208,AKT2,0.474,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
213,ALB,0.317,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
220,ALDH1A3,0.578,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
238,ALK,0.396,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
238,ALK,0.396,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
238,ALK,0.396,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,2012,2013,2,0,BEFREE
238,ALK,0.396,0.846,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
238,ALK,0.396,0.846,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,2012,2013,2,0,BEFREE
285,ANGPT2,0.41,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
301,ANXA1,0.442,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
301,ANXA1,0.442,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
301,ANXA1,0.442,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
302,ANXA2,0.453,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,1992,1992,1,0,BEFREE
324,APC,0.373,0.962,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
324,APC,0.373,0.962,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
324,APC,0.373,0.962,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
324,APC,0.373,0.962,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
332,BIRC5,0.495,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
332,BIRC5,0.495,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
347,APOD,0.584,0.577,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2006,1,0,CTD_human
351,APP,0.422,0.846,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2010,2010,1,0,BEFREE
355,FAS,0.372,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.21,1,2000,2018,2,0,BEFREE;RGD
356,FASLG,0.43,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.21,1,2000,2018,2,0,BEFREE;RGD
367,AR,0.351,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,1997,2007,2,0,BEFREE
367,AR,0.351,0.846,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
367,AR,0.351,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2020,2020,1,0,BEFREE
390,RND3,0.656,0.385,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
396,ARHGDIA,0.663,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,LHGDN
410,ARSA,0.448,0.923,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2004,2004,1,0,BEFREE
429,ASCL1,0.552,0.692,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
429,ASCL1,0.552,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
429,ASCL1,0.552,0.692,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
429,ASCL1,0.552,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
435,ASL,0.593,0.731,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
472,ATM,0.374,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.11,1,2007,2007,1,0,BEFREE;CLINVAR
482,ATP1B2,0.705,0.308,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2006,1,0,CTD_human
546,ATRX,0.452,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.07,1,2014,2019,7,0,BEFREE
546,ATRX,0.452,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.13,1,2015,2019,3,0,BEFREE;HPO
546,ATRX,0.452,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2013,2014,2,0,CTD_human
546,ATRX,0.452,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2015,2019,3,0,BEFREE
546,ATRX,0.452,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2015,2019,3,0,BEFREE
546,ATRX,0.452,0.808,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
546,ATRX,0.452,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.07,1,2014,2019,7,0,BEFREE
572,BAD,0.553,0.769,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
581,BAX,0.417,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.2,1,2017,2018,2,0,RGD
595,CCND1,0.344,0.923,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.02,1,2008,2015,2,0,BEFREE
595,CCND1,0.344,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
595,CCND1,0.344,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.11,1,2014,2014,1,0,BEFREE;HPO
595,CCND1,0.344,0.923,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,2015,2017,2,0,BEFREE
595,CCND1,0.344,0.923,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
595,CCND1,0.344,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
595,CCND1,0.344,0.923,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,2015,2017,2,0,BEFREE
596,BCL2,0.291,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,1995,1995,1,0,BEFREE
596,BCL2,0.291,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1999,2011,3,0,BEFREE
596,BCL2,0.291,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
596,BCL2,0.291,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1994,2013,2,0,BEFREE
596,BCL2,0.291,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1999,2011,3,0,BEFREE
596,BCL2,0.291,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1999,2011,3,0,BEFREE
596,BCL2,0.291,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
596,BCL2,0.291,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,2011,2,0,BEFREE
596,BCL2,0.291,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1999,2011,3,0,BEFREE
596,BCL2,0.291,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
596,BCL2,0.291,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.2,1,2017,2018,2,0,RGD
596,BCL2,0.291,0.885,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1994,2013,2,0,BEFREE
598,BCL2L1,0.493,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,LHGDN
604,BCL6,0.444,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
604,BCL6,0.444,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
627,BDNF,0.345,0.923,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
627,BDNF,0.345,0.923,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
627,BDNF,0.345,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
648,BMI1,0.448,0.808,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2018,2018,1,0,CTD_human
648,BMI1,0.448,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2013,2013,1,0,CTD_human
648,BMI1,0.448,0.808,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2018,2018,1,0,CTD_human
648,BMI1,0.448,0.808,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2018,2018,1,0,CTD_human
648,BMI1,0.448,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
652,BMP4,0.422,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
673,BRAF,0.319,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.06,1,2012,2019,6,2,BEFREE
673,BRAF,0.319,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
673,BRAF,0.319,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.2,0.974,2011,2020,38,3,BEFREE;CLINVAR
673,BRAF,0.319,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.03,1,2005,2020,3,2,BEFREE;LHGDN
673,BRAF,0.319,0.846,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2013,2013,1,0,CTD_human
673,BRAF,0.319,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2012,2019,5,2,BEFREE
673,BRAF,0.319,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2012,2019,5,2,BEFREE
673,BRAF,0.319,0.846,C0431112,Anaplastic ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,2,BEFREE
673,BRAF,0.319,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.06,1,2012,2019,6,2,BEFREE
673,BRAF,0.319,0.846,C1321878,Desmoplastic infantile ganglioglioma,disease,,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
673,BRAF,0.319,0.846,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.2,1,2011,2020,21,3,BEFREE;CLINVAR
673,BRAF,0.319,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.05,1,2017,2020,5,2,BEFREE
673,BRAF,0.319,0.846,C2347979,Rosette-forming glioneuronal tumor of the fourth ventricle,disease,C04;C10,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
673,BRAF,0.319,0.846,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.1,0.933,2014,2019,15,2,BEFREE
673,BRAF,0.319,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.03,1,2015,2019,3,2,BEFREE
675,BRCA2,0.379,0.846,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,NA,NA,NA,0,0,CTD_human
706,TSPO,0.444,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
706,TSPO,0.444,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
767,CA8,0.595,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
767,CA8,0.595,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
768,CA9,0.483,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
768,CA9,0.483,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
768,CA9,0.483,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
768,CA9,0.483,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
778,CACNA1F,0.595,0.5,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,0.5,2008,2014,2,0,BEFREE
778,CACNA1F,0.595,0.5,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
778,CACNA1F,0.595,0.5,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,0.5,2008,2014,2,0,BEFREE
794,CALB2,0.545,0.692,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2020,2020,1,0,BEFREE
796,CALCA,0.416,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,0.5,2012,2015,2,0,BEFREE
796,CALCA,0.416,0.923,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
796,CALCA,0.416,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
799,CALCR,0.464,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
801,CALM1,0.472,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,0,2019,2019,1,0,BEFREE
801,CALM1,0.472,0.808,C1708957,Mediastinal Paraganglioma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
805,CALM2,0.472,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,0,2019,2019,1,0,BEFREE
805,CALM2,0.472,0.808,C1708957,Mediastinal Paraganglioma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
808,CALM3,0.485,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,0,2019,2019,1,0,BEFREE
808,CALM3,0.485,0.846,C1708957,Mediastinal Paraganglioma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
810,CALML3,0.621,0.5,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
822,CAPG,0.548,0.731,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
836,CASP3,0.351,0.923,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
836,CASP3,0.351,0.923,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
836,CASP3,0.351,0.923,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
836,CASP3,0.351,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
836,CASP3,0.351,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.2,1,2018,2018,1,0,RGD
846,CASR,0.41,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
847,CAT,0.359,0.962,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2011,2011,1,0,CTD_human
857,CAV1,0.388,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2007,2019,4,0,BEFREE
857,CAV1,0.388,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2007,2019,4,0,BEFREE
857,CAV1,0.388,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,2016,2019,2,0,BEFREE
885,CCK,0.453,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.02,1,2003,2003,2,0,BEFREE
887,CCKBR,0.573,0.615,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
889,KRIT1,0.5,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,0,2019,2019,1,0,BEFREE
889,KRIT1,0.5,0.808,C1708957,Mediastinal Paraganglioma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
890,CCNA2,0.578,0.654,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,LHGDN
891,CCNB1,0.512,0.731,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,LHGDN
947,CD34,0.368,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
947,CD34,0.368,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.05,1,2002,2019,5,0,BEFREE
947,CD34,0.368,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
947,CD34,0.368,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
947,CD34,0.368,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
947,CD34,0.368,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
947,CD34,0.368,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
948,CD36,0.446,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
960,CD44,0.363,0.962,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.03,1,1994,1997,3,0,BEFREE
960,CD44,0.363,0.962,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2002,2003,2,0,LHGDN
960,CD44,0.363,0.962,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
960,CD44,0.363,0.962,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1997,1997,2,0,BEFREE
960,CD44,0.363,0.962,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
960,CD44,0.363,0.962,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1997,1997,2,0,BEFREE
965,CD58,0.584,0.769,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1991,1991,1,0,BEFREE
965,CD58,0.584,0.769,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1991,1991,1,0,BEFREE
967,CD63,0.542,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
967,CD63,0.542,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
970,CD70,0.542,0.692,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
977,CD151,0.564,0.654,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
983,CDK1,0.482,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE;LHGDN
999,CDH1,0.401,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
999,CDH1,0.401,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
999,CDH1,0.401,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,0,2012,2012,1,0,BEFREE
1017,CDK2,0.456,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,1999,2,0,BEFREE
1017,CDK2,0.456,0.692,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
1017,CDK2,0.456,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,1999,2,0,BEFREE
1017,CDK2,0.456,0.692,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
1019,CDK4,0.412,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1019,CDK4,0.412,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
1019,CDK4,0.412,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1019,CDK4,0.412,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2001,2008,2,0,BEFREE
1019,CDK4,0.412,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1019,CDK4,0.412,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1020,CDK5,0.495,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
1022,CDK7,0.566,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
1026,CDKN1A,0.403,0.769,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1027,CDKN1B,0.409,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,2010,2,0,BEFREE
1027,CDKN1B,0.409,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.04,0.75,2007,2014,4,0,BEFREE
1027,CDKN1B,0.409,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,2010,2,0,BEFREE
1028,CDKN1C,0.456,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
1029,CDKN2A,0.3,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.1,0.889,1999,2018,18,0,BEFREE
1029,CDKN2A,0.3,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.03,1,2008,2014,3,0,BEFREE;LHGDN
1029,CDKN2A,0.3,0.885,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
1029,CDKN2A,0.3,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.03,0.667,2003,2018,3,0,BEFREE
1029,CDKN2A,0.3,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.02,1,2000,2016,2,0,BEFREE
1029,CDKN2A,0.3,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2005,2009,2,0,CTD_human
1029,CDKN2A,0.3,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2003,2016,4,0,BEFREE
1029,CDKN2A,0.3,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2003,2016,4,0,BEFREE
1029,CDKN2A,0.3,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,1998,2009,4,0,BEFREE
1029,CDKN2A,0.3,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.1,1,1998,2019,10,0,BEFREE
1029,CDKN2A,0.3,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.1,0.889,1999,2018,18,0,BEFREE
1029,CDKN2A,0.3,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,1998,2009,4,0,BEFREE
1029,CDKN2A,0.3,0.885,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.02,0.5,2003,2007,2,0,BEFREE
1029,CDKN2A,0.3,0.885,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
1029,CDKN2A,0.3,0.885,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2018,2019,2,0,BEFREE
1029,CDKN2A,0.3,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.05,1,2002,2019,5,0,BEFREE
1030,CDKN2B,0.417,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1996,2011,3,0,BEFREE
1030,CDKN2B,0.417,0.769,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2009,2009,2,0,CTD_human
1030,CDKN2B,0.417,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
1030,CDKN2B,0.417,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
1030,CDKN2B,0.417,0.769,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1030,CDKN2B,0.417,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1996,2011,3,0,BEFREE
1031,CDKN2C,0.527,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,1999,2016,5,0,BEFREE
1031,CDKN2C,0.527,0.654,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,1999,2,0,BEFREE
1031,CDKN2C,0.527,0.654,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,1999,2,0,BEFREE
1031,CDKN2C,0.527,0.654,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
1031,CDKN2C,0.527,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,1999,2016,5,0,BEFREE
1032,CDKN2D,0.547,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
1032,CDKN2D,0.547,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
1048,CEACAM5,0.42,0.846,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1072,CFL1,0.529,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1072,CFL1,0.529,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1084,CEACAM3,0.494,0.731,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1087,CEACAM7,0.494,0.769,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1111,CHEK1,0.492,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
1113,CHGA,0.49,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.07,1,2009,2019,7,2,BEFREE
1113,CHGA,0.49,0.808,C1332562,Bladder Paraganglioma,disease,C04;C13;C12,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
1114,CHGB,0.599,0.654,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
1116,CHI3L1,0.419,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
1116,CHI3L1,0.419,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2011,2011,1,0,CTD_human
1116,CHI3L1,0.419,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
1116,CHI3L1,0.419,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
1116,CHI3L1,0.419,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2014,2016,2,0,BEFREE
1118,CHIT1,0.525,0.692,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2019,2019,1,0,BEFREE
1181,CLCN2,0.626,0.462,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2003,2003,1,0,CTD_human
1182,CLCN3,0.621,0.615,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2003,2003,1,0,CTD_human
1184,CLCN5,0.593,0.577,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2003,2003,1,0,CTD_human
1200,TPP1,0.551,0.808,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,2001,2001,1,0,BEFREE
1201,CLN3,0.572,0.692,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,2001,2001,1,0,BEFREE
1233,CCR4,0.51,0.731,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2008,2008,1,0,CTD_human
1267,CNP,0.604,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
1267,CNP,0.604,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
1285,COL4A3,0.552,0.692,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
1302,COL11A2,0.435,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
1316,KLF6,0.501,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2000,2003,2,0,BEFREE
1316,KLF6,0.501,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2000,2003,2,0,BEFREE
1316,KLF6,0.501,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1325,CORT,0.641,0.654,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1326,MAP3K8,0.516,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1326,MAP3K8,0.516,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1326,MAP3K8,0.516,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1326,MAP3K8,0.516,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
1351,COX8A,0.4,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
1351,COX8A,0.4,0.846,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2000,2000,1,0,BEFREE
1351,COX8A,0.4,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2000,2000,1,0,BEFREE
1351,COX8A,0.4,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
1351,COX8A,0.4,0.846,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2000,2000,1,0,BEFREE
1356,CP,0.466,0.846,C0854279,Basal ganglion degeneration,disease,,Disease or Syndrome,0.01,1,1995,1995,1,0,BEFREE
1363,CPE,0.584,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
1363,CPE,0.584,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
1385,CREB1,0.463,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
1385,CREB1,0.463,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
1385,CREB1,0.463,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
1385,CREB1,0.463,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
1392,CRH,0.439,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
1421,CRYGD,0.51,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.05,1,2015,2018,5,0,BEFREE
1421,CRYGD,0.51,0.808,C0334415,Sympathetic paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
1431,CS,0.59,0.654,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
1434,CSE1L,0.521,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1434,CSE1L,0.521,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1434,CSE1L,0.521,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1434,CSE1L,0.521,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1437,CSF2,0.33,0.962,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
1437,CSF2,0.33,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
1438,CSF2RA,0.67,0.615,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
1462,VCAN,0.497,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
1464,CSPG4,0.599,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
1464,CSPG4,0.599,0.615,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
1464,CSPG4,0.599,0.615,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
1464,CSPG4,0.599,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
1499,CTNNB1,0.303,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2013,2015,2,0,BEFREE
1499,CTNNB1,0.303,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
1499,CTNNB1,0.303,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2013,2015,2,0,BEFREE
1499,CTNNB1,0.303,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2013,2015,2,0,BEFREE
1499,CTNNB1,0.303,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2013,2015,2,0,BEFREE
1499,CTNNB1,0.303,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.03,1,2016,2016,3,0,BEFREE
1523,CUX1,0.465,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
1523,CUX1,0.465,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
1523,CUX1,0.465,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1555,CYP2B6,0.428,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,1998,2001,2,0,CTD_human
1562,CYP2C18,0.666,0.731,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,1998,1998,1,0,CTD_human
1576,CYP3A4,0.462,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
1587,ADAM3A,0.792,0.231,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
1600,DAB1,0.626,0.615,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE;LHGDN
1611,DAP,0.53,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1611,DAP,0.53,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1611,DAP,0.53,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1611,DAP,0.53,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1612,DAPK1,0.472,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1612,DAPK1,0.472,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1612,DAPK1,0.472,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1612,DAPK1,0.472,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1613,DAPK3,0.612,0.654,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
1616,DAXX,0.544,0.692,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
1621,DBH,0.511,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
1633,DCK,0.561,0.692,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1641,DCX,0.511,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
1641,DCX,0.511,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2006,2,0,BEFREE
1641,DCX,0.511,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.03,1,2002,2006,3,0,BEFREE
1641,DCX,0.511,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
1641,DCX,0.511,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
1641,DCX,0.511,0.769,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
1641,DCX,0.511,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2006,2,0,BEFREE
1641,DCX,0.511,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
1647,GADD45A,0.526,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
1657,DMXL1,0.805,0.154,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2006,1,0,CTD_human
1674,DES,0.46,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1995,2011,2,0,BEFREE
1674,DES,0.46,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1995,1995,1,0,BEFREE
1674,DES,0.46,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1995,1995,1,0,BEFREE
1674,DES,0.46,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1995,2011,2,0,BEFREE
1674,DES,0.46,0.846,C1321878,Desmoplastic infantile ganglioglioma,disease,,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
1677,DFFB,0.7,0.346,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,LHGDN
1730,DIAPH2,0.678,0.538,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2014,2018,2,0,BEFREE
1730,DIAPH2,0.678,0.538,C1321878,Desmoplastic infantile ganglioglioma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
1730,DIAPH2,0.678,0.538,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2014,2018,2,0,BEFREE
1743,DLST,0.653,0.615,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.11,1,2019,2019,1,0,BEFREE;HPO
1743,DLST,0.653,0.615,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
1755,DMBT1,0.533,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
1755,DMBT1,0.533,0.654,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
1755,DMBT1,0.533,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
1757,SARDH,0.523,0.846,C0007279,Carotid Body Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1757,SARDH,0.523,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,1,2003,2020,58,0,BEFREE
1757,SARDH,0.523,0.846,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
1757,SARDH,0.523,0.846,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.06,1,2003,2020,6,0,BEFREE
1757,SARDH,0.523,0.846,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.02,1,2011,2014,2,0,BEFREE
1757,SARDH,0.523,0.846,C1533592,Malignant Paraganglionic Neoplasm,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
1773,DNASE1,0.505,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
1773,DNASE1,0.505,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
1773,DNASE1,0.505,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
1773,DNASE1,0.505,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
1788,DNMT3A,0.445,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
1806,DPYD,0.493,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
1813,DRD2,0.436,0.846,C4289688,"Diffuse midline glioma, point mutation K27M in histone H3",disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
1822,ATN1,0.409,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1822,ATN1,0.409,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1822,ATN1,0.409,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1822,ATN1,0.409,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
1825,DSC3,0.57,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2019,2019,2,0,BEFREE
1825,DSC3,0.57,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
1825,DSC3,0.57,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
1825,DSC3,0.57,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2019,2019,2,0,BEFREE
1825,DSC3,0.57,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.03,1,2017,2017,3,0,BEFREE
1840,DTX1,0.656,0.5,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
1840,DTX1,0.656,0.5,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
1840,DTX1,0.656,0.5,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
1840,DTX1,0.656,0.5,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
1840,DTX1,0.656,0.5,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
1840,DTX1,0.656,0.5,C0751395,Mixed Oligodendroglioma-Ependymoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
1840,DTX1,0.656,0.5,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
1844,DUSP2,0.558,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1844,DUSP2,0.558,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1847,DUSP5,0.597,0.654,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
1847,DUSP5,0.597,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
1859,DYRK1A,0.533,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
1859,DYRK1A,0.533,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
1859,DYRK1A,0.533,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
1859,DYRK1A,0.533,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
1869,E2F1,0.441,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
1889,ECE1,0.541,0.769,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,1999,1999,1,0,CTD_human
1889,ECE1,0.541,0.769,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,1999,1999,1,0,CTD_human
1889,ECE1,0.541,0.769,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,1999,1999,1,0,CTD_human
1890,TYMP,0.495,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1894,ECT2,0.603,0.615,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
1894,ECT2,0.603,0.615,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
1908,EDN3,0.608,0.577,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
1908,EDN3,0.608,0.577,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.52,1,1996,2009,7,0,BEFREE;CTD_human;GENOMICS_ENGLAND
1908,EDN3,0.608,0.577,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
1908,EDN3,0.608,0.577,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,1996,1998,4,0,CTD_human
1908,EDN3,0.608,0.577,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,1996,1998,4,0,CTD_human
1909,EDNRA,0.426,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
1910,EDNRB,0.47,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,LHGDN
1910,EDNRB,0.47,0.846,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.65,1,1996,2015,7,2,BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND
1910,EDNRB,0.47,0.846,C0345240,Total intestinal aganglionosis,disease,C16;C06,Congenital Abnormality,0.3,1,2011,2011,1,2,CLINVAR;RGD
1910,EDNRB,0.47,0.846,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,1996,1996,1,0,CTD_human
1910,EDNRB,0.47,0.846,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,1996,1996,1,0,CTD_human
1910,EDNRB,0.47,0.846,C4023346,Aganglionosis of the small intestine,phenotype,,Anatomical Abnormality,0.1,NA,NA,NA,0,2,CLINVAR
1950,EGF,0.357,0.923,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
1950,EGF,0.357,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,2010,2012,2,1,BEFREE
1956,EGFR,0.295,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.1,1,1992,2014,17,0,BEFREE;LHGDN
1956,EGFR,0.295,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,1992,2008,2,0,BEFREE
1956,EGFR,0.295,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.31,1,2008,2013,3,0,BEFREE;ORPHANET
1956,EGFR,0.295,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,1992,2014,5,0,BEFREE
1956,EGFR,0.295,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,1992,2014,5,0,BEFREE
1956,EGFR,0.295,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1996,2011,3,0,BEFREE
1956,EGFR,0.295,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.06,1,1996,2011,6,0,BEFREE
1956,EGFR,0.295,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.1,1,1992,2014,17,0,BEFREE
1956,EGFR,0.295,0.885,C1272516,Small cell glioblastoma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
1956,EGFR,0.295,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1996,2011,3,0,BEFREE
1956,EGFR,0.295,0.885,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
1956,EGFR,0.295,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.04,1,2002,2011,4,0,BEFREE
1956,EGFR,0.295,0.885,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2016,2016,1,1,BEFREE
1956,EGFR,0.295,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.06,1,2002,2018,6,0,BEFREE
1958,EGR1,0.433,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
1978,EIF4EBP1,0.494,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2004,ELK3,0.49,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2014,EMP3,0.619,0.423,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
2014,EMP3,0.619,0.423,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
2014,EMP3,0.619,0.423,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
2014,EMP3,0.619,0.423,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
2014,EMP3,0.619,0.423,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2014,EMP3,0.619,0.423,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2022,ENG,0.446,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2026,ENO2,0.475,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2026,ENO2,0.475,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2026,ENO2,0.475,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2026,ENO2,0.475,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2026,ENO2,0.475,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2028,ENPEP,0.564,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2034,EPAS1,0.454,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
2034,EPAS1,0.454,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.4,1,2006,2019,20,0,BEFREE;GENOMICS_ENGLAND
2034,EPAS1,0.454,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
2034,EPAS1,0.454,0.731,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2013,2016,3,0,CLINGEN
2034,EPAS1,0.454,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2047,EPHB1,0.518,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2048,EPHB2,0.374,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
2048,EPHB2,0.374,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2048,EPHB2,0.374,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
2048,EPHB2,0.374,0.846,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2048,EPHB2,0.374,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2010,2017,2,0,BEFREE
2064,ERBB2,0.328,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2008,2012,2,0,BEFREE
2064,ERBB2,0.328,0.923,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,NA,NA,NA,0,0,CTD_human
2064,ERBB2,0.328,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2012,2012,2,0,BEFREE
2065,ERBB3,0.448,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
2065,ERBB3,0.448,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
2065,ERBB3,0.448,0.808,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
2067,ERCC1,0.445,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,1,BEFREE
2068,ERCC2,0.42,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,1,BEFREE;LHGDN
2068,ERCC2,0.42,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,1,BEFREE
2068,ERCC2,0.42,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
2099,ESR1,0.324,0.962,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
2099,ESR1,0.324,0.962,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
2118,ETV4,0.545,0.5,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
2118,ETV4,0.545,0.5,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
2120,ETV6,0.477,0.731,C0431111,Rhabdomyosarcoma with ganglionic differentiation,disease,C04;C05,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
2130,EWSR1,0.474,0.692,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
2130,EWSR1,0.474,0.692,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
2130,EWSR1,0.474,0.692,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
2146,EZH2,0.376,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
2146,EZH2,0.376,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
2146,EZH2,0.376,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
2146,EZH2,0.376,0.885,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
2146,EZH2,0.376,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
2146,EZH2,0.376,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2146,EZH2,0.376,0.885,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2149,F2R,0.444,0.846,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.02,1,2014,2018,2,0,BEFREE
2150,F2RL1,0.48,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
2152,F3,0.415,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
2152,F3,0.415,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
2158,F9,0.465,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2158,F9,0.465,0.885,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2194,FASN,0.474,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
2194,FASN,0.474,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
2195,FAT1,0.508,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
2217,FCGRT,0.563,0.654,C2749283,"Gm2-Gangliosidosis, Variant B1",disease,C16;C18;C10,Disease or Syndrome,0.02,1,1988,1990,2,0,BEFREE
2220,FCN2,0.517,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
2247,FGF2,0.383,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
2247,FGF2,0.383,0.923,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2000,2000,1,0,CTD_human
2247,FGF2,0.383,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
2247,FGF2,0.383,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
2247,FGF2,0.383,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
2247,FGF2,0.383,0.923,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2253,FGF8,0.507,0.769,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
2253,FGF8,0.507,0.769,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
2260,FGFR1,0.362,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2017,2018,3,0,BEFREE
2260,FGFR1,0.362,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2007,2014,2,0,BEFREE
2260,FGFR1,0.362,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2017,2019,2,0,BEFREE
2260,FGFR1,0.362,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,2012,2012,1,0,ORPHANET
2260,FGFR1,0.362,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2013,2013,1,0,CTD_human
2260,FGFR1,0.362,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2260,FGFR1,0.362,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2260,FGFR1,0.362,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2017,2018,3,0,BEFREE
2260,FGFR1,0.362,0.885,C4331262,Rosette-forming glioneuronal neoplasm,disease,,Neoplastic Process,0.1,NA,NA,NA,0,1,CLINVAR
2260,FGFR1,0.362,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2261,FGFR3,0.391,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
2261,FGFR3,0.391,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2261,FGFR3,0.391,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,2012,2012,1,0,ORPHANET
2271,FH,0.489,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.09,1,2003,2019,9,0,BEFREE
2271,FH,0.489,0.846,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2011,2011,1,0,BEFREE
2271,FH,0.489,0.846,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
2271,FH,0.489,0.846,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2005,2015,6,0,CLINGEN
2277,VEGFD,0.538,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
2305,FOXM1,0.441,0.769,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2305,FOXM1,0.441,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2308,FOXO1,0.433,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
2315,MLANA,0.579,0.692,C1332562,Bladder Paraganglioma,disease,C04;C13;C12,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
2321,FLT1,0.419,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
2321,FLT1,0.419,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2014,2015,2,0,BEFREE
2321,FLT1,0.419,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
2321,FLT1,0.419,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
2321,FLT1,0.419,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
2321,FLT1,0.419,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
2321,FLT1,0.419,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2323,FLT3LG,0.564,0.577,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
2324,FLT4,0.457,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
2334,AFF2,0.636,0.538,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
2334,AFF2,0.636,0.538,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
2334,AFF2,0.636,0.538,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
2334,AFF2,0.636,0.538,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
2335,FN1,0.365,0.962,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.01,1,2017,2017,1,0,BEFREE
2346,FOLH1,0.453,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2346,FOLH1,0.453,0.885,C1332562,Bladder Paraganglioma,disease,C04;C13;C12,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2346,FOLH1,0.453,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2395,FXN,0.51,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2395,FXN,0.51,0.654,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2395,FXN,0.51,0.654,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2395,FXN,0.51,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2444,FRK,0.674,0.5,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2475,MTOR,0.343,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2014,2019,2,0,BEFREE
2495,FTH1,0.559,0.731,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2011,2011,1,0,CTD_human
2512,FTL,0.559,0.692,C0854279,Basal ganglion degeneration,disease,,Disease or Syndrome,0.02,0.5,2002,2007,2,0,BEFREE
2512,FTL,0.559,0.692,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2526,FUT4,0.505,0.731,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2526,FUT4,0.505,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2563,GABRD,0.558,0.692,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2596,GAP43,0.564,0.731,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
2597,GAPDH,0.447,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1990,2003,2,0,BEFREE
2597,GAPDH,0.447,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.2,1,2015,2015,1,0,RGD
2597,GAPDH,0.447,0.808,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1990,2003,2,0,BEFREE
2619,GAS1,0.587,0.654,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
2625,GATA3,0.415,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2629,GBA,0.5,0.808,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
2644,GCHFR,0.579,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
2668,GDNF,0.434,0.885,C0013375,Dysganglionosis,disease,C16,Congenital Abnormality,0.01,1,1998,1998,1,0,BEFREE
2668,GDNF,0.434,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
2668,GDNF,0.434,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
2668,GDNF,0.434,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
2668,GDNF,0.434,0.885,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,1996,1996,2,0,CTD_human
2668,GDNF,0.434,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
2668,GDNF,0.434,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
2668,GDNF,0.434,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
2668,GDNF,0.434,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
2668,GDNF,0.434,0.885,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
2668,GDNF,0.434,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
2668,GDNF,0.434,0.885,C0546275,Hypoganglionosis,disease,,Disease or Syndrome,0.01,1,2001,2001,1,0,BEFREE
2668,GDNF,0.434,0.885,C0751395,Mixed Oligodendroglioma-Ependymoma,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
2668,GDNF,0.434,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
2668,GDNF,0.434,0.885,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,1996,1996,2,0,CTD_human
2668,GDNF,0.434,0.885,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,1997,1997,1,0,CLINGEN
2668,GDNF,0.434,0.885,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,1996,1996,2,0,CTD_human
2668,GDNF,0.434,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2670,GFAP,0.421,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
2670,GFAP,0.421,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.1,0.9,1993,2012,10,0,BEFREE;LHGDN
2670,GFAP,0.421,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
2670,GFAP,0.421,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
2670,GFAP,0.421,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,1994,2012,4,0,BEFREE
2670,GFAP,0.421,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,1994,2012,4,0,BEFREE
2670,GFAP,0.421,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2670,GFAP,0.421,0.885,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
2670,GFAP,0.421,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2001,2007,2,0,BEFREE
2670,GFAP,0.421,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.09,0.889,1993,2012,9,0,BEFREE
2670,GFAP,0.421,0.885,C1272516,Small cell glioblastoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2670,GFAP,0.421,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2670,GFAP,0.421,0.885,C1504559,Retinal gliosis,disease,,Disease or Syndrome,0.01,1,2010,2010,1,0,BEFREE
2670,GFAP,0.421,0.885,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2670,GFAP,0.421,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2697,GJA1,0.393,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
2720,GLB1,0.448,0.808,C0017083,Gangliosidoses,disease,C16;C18;C10,Disease or Syndrome,0.06,1,1979,2017,6,0,BEFREE;LHGDN
2720,GLB1,0.448,0.808,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.7,0.99,1975,2019,103,30,BEFREE;CLINVAR;CTD_human;LHGDN;MGD
2720,GLB1,0.448,0.808,C0268271,"Gangliosidosis, Generalized GM1, Type 1 (disorder)",disease,C16;C18;C10,Disease or Syndrome,0.76,0.982,1979,2017,57,77,BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND;UNIPROT
2720,GLB1,0.448,0.808,C0268272,"Gangliosidosis, Generalized GM1, Type 2",disease,C16;C18;C10,Disease or Syndrome,0.73,1,1991,2018,51,60,BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND;UNIPROT
2720,GLB1,0.448,0.808,C0268273,"Gangliosidosis, Generalized GM1, Type 3",disease,C16;C18;C10,Disease or Syndrome,0.72,1,1984,2017,50,52,BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND;UNIPROT
2720,GLB1,0.448,0.808,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,2013,2013,1,0,BEFREE
2720,GLB1,0.448,0.808,C1968748,"Gangliosidosis, Generalized GM1, Type I, with Cardiac Involvement",disease,C16;C18;C10;C14,Disease or Syndrome,0.1,NA,NA,NA,0,4,CLINVAR
2735,GLI1,0.431,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
2736,GLI2,0.446,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2736,GLI2,0.446,0.846,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
2747,GLUD2,0.678,0.423,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
2752,GLUL,0.513,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2752,GLUL,0.513,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2752,GLUL,0.513,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2752,GLUL,0.513,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
2760,GM2A,0.678,0.692,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.04,1,1999,2016,4,0,BEFREE
2760,GM2A,0.678,0.692,C1848920,GM2-ganglioside accumulation,phenotype,,Finding,0.1,NA,NA,NA,0,0,HPO
2768,GNA12,0.547,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
2768,GNA12,0.547,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
2783,GNB2,0.743,0.192,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2896,GRN,0.435,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
2902,GRIN1,0.561,0.692,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
2903,GRIN2A,0.522,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
2909,ARHGAP35,0.751,0.269,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
2909,ARHGAP35,0.751,0.269,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
2915,GRM5,0.525,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
2932,GSK3B,0.43,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
2944,GSTM1,0.38,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,LHGDN
2950,GSTP1,0.383,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,LHGDN
2950,GSTP1,0.383,0.923,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2006,1,0,CTD_human
2950,GSTP1,0.383,0.923,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.01,1,1996,1996,1,0,BEFREE
2952,GSTT1,0.393,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1997,2006,2,0,BEFREE
2952,GSTT1,0.393,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1997,2006,2,0,BEFREE
2952,GSTT1,0.393,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1997,2006,2,0,BEFREE
2952,GSTT1,0.393,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1997,2006,2,0,BEFREE
2956,MSH6,0.462,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
2956,MSH6,0.462,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
2956,MSH6,0.462,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
2956,MSH6,0.462,0.731,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2014,2,0,BEFREE
2956,MSH6,0.462,0.731,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2014,2,0,BEFREE
2956,MSH6,0.462,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
2956,MSH6,0.462,0.731,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2014,2,0,BEFREE
2990,GUSB,0.53,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
3020,H3-3A,0.559,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3020,H3-3A,0.559,0.692,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,1,BEFREE
3020,H3-3A,0.559,0.692,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2012,2013,2,0,CTD_human
3020,H3-3A,0.559,0.692,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3020,H3-3A,0.559,0.692,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3020,H3-3A,0.559,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3020,H3-3A,0.559,0.692,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,1,BEFREE
3020,H3-3A,0.559,0.692,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3020,H3-3A,0.559,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,3,BEFREE
3021,H3-3B,0.599,0.385,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3021,H3-3B,0.599,0.385,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3021,H3-3B,0.599,0.385,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3021,H3-3B,0.599,0.385,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3021,H3-3B,0.599,0.385,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3021,H3-3B,0.599,0.385,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3021,H3-3B,0.599,0.385,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3021,H3-3B,0.599,0.385,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3059,HCLS1,0.539,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3059,HCLS1,0.539,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3059,HCLS1,0.539,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
3073,HEXA,0.633,0.615,C0017083,Gangliosidoses,disease,C16;C18;C10,Disease or Syndrome,0.03,1,1997,2004,3,2,BEFREE
3073,HEXA,0.633,0.615,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.07,0.857,1993,2013,7,4,BEFREE
3073,HEXA,0.633,0.615,C0268276,Juvenile GM 2 gangliosidosis,disease,C16;C18;C10,Disease or Syndrome,0.11,1,2008,2008,1,2,BEFREE;CLINVAR
3073,HEXA,0.633,0.615,C1848920,GM2-ganglioside accumulation,phenotype,,Finding,0.1,NA,NA,NA,0,0,HPO
3073,HEXA,0.633,0.615,C2749283,"Gm2-Gangliosidosis, Variant B1",disease,C16;C18;C10,Disease or Syndrome,0.4,NA,NA,NA,0,1,CLINVAR;ORPHANET
3074,HEXB,0.644,0.654,C0017083,Gangliosidoses,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2018,2018,1,0,BEFREE
3074,HEXB,0.644,0.654,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.07,1,1992,2020,7,0,BEFREE
3082,HGF,0.374,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
3082,HGF,0.374,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
3084,NRG1,0.464,0.885,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2012,2012,1,2,CTD_human
3084,NRG1,0.464,0.885,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2012,2012,1,0,CTD_human
3084,NRG1,0.464,0.885,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.4,1,2009,2016,4,2,CTD_human;GWASCAT
3087,HHEX,0.599,0.692,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.03,1,1983,1990,3,0,BEFREE
3090,HIC1,0.522,0.615,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
3090,HIC1,0.522,0.615,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
3091,HIF1A,0.327,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.07,1,2006,2019,7,0,BEFREE
3091,HIF1A,0.327,0.923,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3091,HIF1A,0.327,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,2014,2019,2,0,BEFREE
3091,HIF1A,0.327,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.03,1,2016,2019,3,0,BEFREE
3105,HLA-A,0.37,0.846,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2003,2003,1,0,CTD_human
3106,HLA-B,0.379,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2003,2003,1,0,CTD_human
3107,HLA-C,0.415,0.846,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2003,2003,1,0,CTD_human
3119,HLA-DQB1,0.407,0.885,C4706583,Limbic encephalitis with leucine-rich glioma-inactivated 1 antibodies,disease,C04;C01;C10;C19,Disease or Syndrome,0.3,1,2017,2017,1,0,ORPHANET
3123,HLA-DRB1,0.333,0.923,C4706583,Limbic encephalitis with leucine-rich glioma-inactivated 1 antibodies,disease,C04;C01;C10;C19,Disease or Syndrome,0.3,1,2017,2017,1,0,ORPHANET
3134,HLA-F,0.631,0.654,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3146,HMGB1,0.368,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
3146,HMGB1,0.368,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
3146,HMGB1,0.368,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
3146,HMGB1,0.368,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
3146,HMGB1,0.368,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,2018,2019,2,0,BEFREE
3178,HNRNPA1,0.529,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
3178,HNRNPA1,0.529,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
3205,HOXA9,0.521,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
3206,HOXA10,0.538,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
3209,HOXA13,0.552,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
3240,HP,0.412,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
3258,HPT,0.593,0.692,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
3265,HRAS,0.378,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,2,BEFREE
3265,HRAS,0.378,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2018,2018,1,0,CTD_human
3265,HRAS,0.378,0.885,C0431111,Rhabdomyosarcoma with ganglionic differentiation,disease,C04;C05,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3280,HES1,0.468,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3280,HES1,0.468,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3280,HES1,0.468,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3280,HES1,0.468,0.885,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3280,HES1,0.468,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3280,HES1,0.468,0.885,C0751395,Mixed Oligodendroglioma-Ependymoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3280,HES1,0.468,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3280,HES1,0.468,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
3339,HSPG2,0.438,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3339,HSPG2,0.438,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3339,HSPG2,0.438,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3339,HSPG2,0.438,0.885,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3339,HSPG2,0.438,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3342,HTC2,0.392,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2009,2,0,BEFREE
3342,HTC2,0.392,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
3342,HTC2,0.392,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
3342,HTC2,0.392,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
3342,HTC2,0.392,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
3342,HTC2,0.392,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2009,2,0,BEFREE
3371,TNC,0.433,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3371,TNC,0.433,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3371,TNC,0.433,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3371,TNC,0.433,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3371,TNC,0.433,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3383,ICAM1,0.364,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
3417,IDH1,0.424,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.4,0.986,2008,2020,72,1,BEFREE;CTD_human;LHGDN
3417,IDH1,0.424,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2010,2018,2,0,BEFREE
3417,IDH1,0.424,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.06,0.833,2009,2017,6,0,BEFREE
3417,IDH1,0.424,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.35,1,2008,2019,6,0,BEFREE;ORPHANET
3417,IDH1,0.424,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.31,1,2009,2017,6,0,BEFREE;CTD_human
3417,IDH1,0.424,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.4,1,2010,2020,31,1,BEFREE;CTD_human
3417,IDH1,0.424,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.4,1,2010,2020,31,1,BEFREE;CTD_human
3417,IDH1,0.424,0.808,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.1,1,2010,2019,10,1,BEFREE
3417,IDH1,0.424,0.808,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.37,1,2010,2017,8,1,BEFREE;CTD_human
3417,IDH1,0.424,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.4,0.941,2010,2019,17,1,BEFREE;CTD_human
3417,IDH1,0.424,0.808,C0751395,Mixed Oligodendroglioma-Ependymoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3417,IDH1,0.424,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.4,0.986,2008,2020,72,1,BEFREE;CTD_human
3417,IDH1,0.424,0.808,C1272516,Small cell glioblastoma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3417,IDH1,0.424,0.808,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.1,1,2010,2019,10,1,BEFREE
3417,IDH1,0.424,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.03,0.667,2011,2017,3,0,BEFREE
3417,IDH1,0.424,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.1,1,2010,2020,17,0,BEFREE
3417,IDH1,0.424,0.808,C2363903,Angiocentric glioma,disease,,Neoplastic Process,0.01,1,2012,2012,1,1,BEFREE
3417,IDH1,0.424,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.03,1,2016,2018,3,0,BEFREE
3417,IDH1,0.424,0.808,C4288558,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
3417,IDH1,0.424,0.808,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2017,2018,2,0,BEFREE
3417,IDH1,0.424,0.808,C4329735,Diffuse leptomeningeal glioneuronal neoplasm,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3417,IDH1,0.424,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.1,1,2010,2019,10,1,BEFREE
3418,IDH2,0.434,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.6,1,2009,2019,41,2,BEFREE;CTD_human;ORPHANET
3418,IDH2,0.434,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2010,2019,2,0,BEFREE
3418,IDH2,0.434,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.04,1,2009,2017,4,0,BEFREE
3418,IDH2,0.434,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.02,1,2016,2017,2,0,BEFREE
3418,IDH2,0.434,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.4,1,2010,2019,13,2,BEFREE;CTD_human
3418,IDH2,0.434,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.4,1,2010,2019,13,2,BEFREE;CTD_human
3418,IDH2,0.434,0.808,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2014,2019,5,2,BEFREE
3418,IDH2,0.434,0.808,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.51,1,2009,2015,8,1,BEFREE;CTD_human;ORPHANET
3418,IDH2,0.434,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.58,0.933,2009,2019,15,2,BEFREE;CTD_human;ORPHANET
3418,IDH2,0.434,0.808,C0751395,Mixed Oligodendroglioma-Ependymoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
3418,IDH2,0.434,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.4,1,2009,2019,35,2,BEFREE;CTD_human
3418,IDH2,0.434,0.808,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2014,2019,5,2,BEFREE
3418,IDH2,0.434,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2017,2017,2,0,BEFREE
3418,IDH2,0.434,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.09,1,2010,2019,9,0,BEFREE
3418,IDH2,0.434,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
3418,IDH2,0.434,0.808,C4288558,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
3418,IDH2,0.434,0.808,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
3418,IDH2,0.434,0.808,C4329735,Diffuse leptomeningeal glioneuronal neoplasm,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3418,IDH2,0.434,0.808,C4331262,Rosette-forming glioneuronal neoplasm,disease,,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
3418,IDH2,0.434,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.05,1,2017,2019,5,0,BEFREE
3429,IFI27,0.437,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3429,IFI27,0.437,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
3456,IFNB1,0.421,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
3456,IFNB1,0.421,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
3458,IFNG,0.288,0.962,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
3483,IGFALS,0.511,0.846,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,2001,2001,1,0,BEFREE
3485,IGFBP2,0.478,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1999,2011,3,0,BEFREE
3485,IGFBP2,0.478,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1999,2011,3,0,BEFREE
3485,IGFBP2,0.478,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1999,2011,3,0,BEFREE
3485,IGFBP2,0.478,0.769,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3485,IGFBP2,0.478,0.769,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
3485,IGFBP2,0.478,0.769,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3485,IGFBP2,0.478,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1999,2011,3,0,BEFREE
3485,IGFBP2,0.478,0.769,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3485,IGFBP2,0.478,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3492,IGH,0.473,0.654,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
3516,RBPJ,0.518,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
3553,IL1B,0.276,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3558,IL2,0.336,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1990,1995,2,0,BEFREE
3558,IL2,0.336,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
3558,IL2,0.336,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1990,1995,2,0,BEFREE
3558,IL2,0.336,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1990,1995,2,0,BEFREE
3558,IL2,0.336,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1990,1995,2,0,BEFREE
3560,IL2RB,0.491,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3560,IL2RB,0.491,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1990,1990,1,0,BEFREE
3560,IL2RB,0.491,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3560,IL2RB,0.491,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1990,1990,1,0,BEFREE
3560,IL2RB,0.491,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1990,1990,1,0,BEFREE
3560,IL2RB,0.491,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1990,1990,1,0,BEFREE
3560,IL2RB,0.491,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
3566,IL4R,0.474,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,2,BEFREE
3576,CXCL8,0.31,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
3586,IL10,0.281,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
3592,IL12A,0.491,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
3592,IL12A,0.491,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2008,2008,1,0,CTD_human
3593,IL12B,0.48,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2008,2008,1,0,CTD_human
3596,IL13,0.386,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
3596,IL13,0.386,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
3596,IL13,0.386,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
3596,IL13,0.386,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
3605,IL17A,0.324,0.923,C0546275,Hypoganglionosis,disease,,Disease or Syndrome,0.01,1,2018,2018,1,0,BEFREE
3606,IL18,0.365,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
3636,INPPL1,0.59,0.769,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.02,1,2013,2017,2,0,BEFREE
3642,INSM1,0.584,0.654,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3642,INSM1,0.584,0.654,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2017,2020,2,0,BEFREE
3642,INSM1,0.584,0.654,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3674,ITGA2B,0.493,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3674,ITGA2B,0.493,0.692,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3674,ITGA2B,0.493,0.692,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3674,ITGA2B,0.493,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3678,ITGA5,0.524,0.769,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1997,1997,1,0,BEFREE
3679,ITGA7,0.588,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
3685,ITGAV,0.526,0.769,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1997,1997,1,0,BEFREE
3714,JAG2,0.576,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
3741,KCNA5,0.606,0.5,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,LHGDN
3791,KDR,0.378,0.885,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
3791,KDR,0.378,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3815,KIT,0.366,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
3815,KIT,0.366,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE;LHGDN
3815,KIT,0.366,0.808,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3815,KIT,0.366,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2014,2,0,BEFREE
3815,KIT,0.366,0.808,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3815,KIT,0.366,0.808,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.01,0,2006,2006,1,0,BEFREE
3845,KRAS,0.32,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3916,LAMP1,0.542,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
3925,STMN1,0.458,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,LHGDN
3925,STMN1,0.458,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
3925,STMN1,0.458,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2007,2007,1,0,CTD_human
3925,STMN1,0.458,0.885,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,1997,1997,1,0,BEFREE
3925,STMN1,0.458,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
3925,STMN1,0.458,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
3925,STMN1,0.458,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
3949,LDLR,0.449,0.885,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.01,1,2006,2006,1,0,BEFREE
3956,LGALS1,0.435,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3956,LGALS1,0.435,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3956,LGALS1,0.435,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3956,LGALS1,0.435,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
3958,LGALS3,0.392,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3958,LGALS3,0.392,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
3958,LGALS3,0.392,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3958,LGALS3,0.392,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
3958,LGALS3,0.392,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
3958,LGALS3,0.392,0.846,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
3976,LIF,0.483,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2014,2018,2,0,BEFREE
3976,LIF,0.483,0.769,C1321878,Desmoplastic infantile ganglioglioma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
3976,LIF,0.483,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2014,2018,2,0,BEFREE
3981,LIG4,0.478,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
4040,LRP6,0.536,0.808,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.02,1,2002,2017,2,0,BEFREE
4041,LRP5,0.485,0.846,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,1,1,2001,2017,30,37,BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND;MGD;ORPHANET;UNIPROT
4045,LSAMP,0.558,0.654,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
4089,SMAD4,0.401,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
4089,SMAD4,0.401,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
4092,SMAD7,0.47,0.769,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
4137,MAPT,0.446,0.923,C0520789,Progressive subcortical gliosis,disease,C01;C10,Disease or Syndrome,0.01,1,1999,1999,1,0,BEFREE
4137,MAPT,0.446,0.923,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
4137,MAPT,0.446,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4149,MAX,0.553,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,1,2012,2019,14,0,BEFREE
4149,MAX,0.553,0.769,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.11,1,2017,2017,1,0,BEFREE;HPO
4149,MAX,0.553,0.769,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.6,1,1992,2017,12,5,CLINGEN;CLINVAR;GENOMICS_ENGLAND
4149,MAX,0.553,0.769,C4274332,Hereditary pheochromocytoma and paraganglioma,disease,C04,Disease or Syndrome,0.01,1,2017,2017,1,0,BEFREE
4155,MBP,0.51,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1993,2002,3,0,BEFREE
4155,MBP,0.51,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1993,2002,2,0,BEFREE
4155,MBP,0.51,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1993,2002,2,0,BEFREE
4155,MBP,0.51,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,1993,2002,3,0,BEFREE
4171,MCM2,0.527,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
4175,MCM6,0.666,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4175,MCM6,0.666,0.615,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4175,MCM6,0.666,0.615,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4175,MCM6,0.666,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4175,MCM6,0.666,0.615,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4191,MDH2,0.595,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.34,1,2015,2018,4,0,BEFREE;GENOMICS_ENGLAND
4191,MDH2,0.595,0.731,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
4191,MDH2,0.595,0.731,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2015,2015,1,0,CLINGEN
4192,MDK,0.494,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2011,2011,1,0,CTD_human
4193,MDM2,0.362,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,0.5,1999,2001,2,0,BEFREE
4193,MDM2,0.362,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
4193,MDM2,0.362,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
4193,MDM2,0.362,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,0.5,1999,2001,2,0,BEFREE
4194,MDM4,0.461,0.808,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
4194,MDM4,0.461,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
4194,MDM4,0.461,0.808,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
4194,MDM4,0.461,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4221,MEN1,0.444,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
4221,MEN1,0.444,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.06,1,2006,2019,6,0,BEFREE
4221,MEN1,0.444,0.808,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,1999,2015,5,0,CLINGEN
4233,MET,0.38,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1992,2013,2,0,BEFREE
4233,MET,0.38,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1992,1992,1,0,BEFREE
4233,MET,0.38,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1992,1992,1,0,BEFREE
4233,MET,0.38,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1992,2013,2,0,BEFREE
4233,MET,0.38,0.846,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2016,2016,1,0,CLINGEN
4233,MET,0.38,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4233,MET,0.38,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
4254,KITLG,0.473,0.885,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,1995,1995,1,0,BEFREE
4254,KITLG,0.473,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
4255,MGMT,0.412,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.1,0.938,2002,2019,16,0,BEFREE
4255,MGMT,0.412,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
4255,MGMT,0.412,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2013,2017,2,0,BEFREE
4255,MGMT,0.412,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.36,1,2011,2018,6,0,BEFREE;ORPHANET
4255,MGMT,0.412,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2005,2009,3,0,CTD_human
4255,MGMT,0.412,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.06,1,2005,2019,6,0,BEFREE
4255,MGMT,0.412,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.06,1,2005,2019,6,0,BEFREE
4255,MGMT,0.412,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
4255,MGMT,0.412,0.885,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.03,1,2014,2015,3,0,BEFREE
4255,MGMT,0.412,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.06,1,2005,2014,6,0,BEFREE
4255,MGMT,0.412,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.1,0.938,2002,2019,16,0,BEFREE
4255,MGMT,0.412,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
4255,MGMT,0.412,0.885,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
4255,MGMT,0.412,0.885,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.03,1,2008,2015,3,0,BEFREE
4255,MGMT,0.412,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
4255,MGMT,0.412,0.885,C3897747,recurrent childhood oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
4255,MGMT,0.412,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.05,1,2010,2018,5,0,BEFREE
4267,CD99,0.491,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
4267,CD99,0.491,0.731,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
4267,CD99,0.491,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
4286,MITF,0.499,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,1,BEFREE
4286,MITF,0.499,0.808,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2016,2016,1,0,CLINGEN
4287,ATXN3,0.521,0.808,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
4288,MKI67,0.431,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2003,2018,5,0,BEFREE
4288,MKI67,0.431,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
4288,MKI67,0.431,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
4288,MKI67,0.431,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2003,2009,2,0,BEFREE
4288,MKI67,0.431,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2003,2009,2,0,BEFREE
4288,MKI67,0.431,0.808,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.02,1,2007,2009,2,0,BEFREE
4288,MKI67,0.431,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,1999,2,0,BEFREE
4288,MKI67,0.431,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2003,2018,5,0,BEFREE
4312,MMP1,0.385,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
4313,MMP2,0.333,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4318,MMP9,0.305,0.923,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
4323,MMP14,0.447,0.769,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
4331,MNAT1,0.539,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
4345,CD200,0.529,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4363,ABCC1,0.445,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4436,MSH2,0.406,0.808,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
4436,MSH2,0.406,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
4436,MSH2,0.406,0.808,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
4437,MSH3,0.474,0.769,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4440,MSI1,0.55,0.615,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2020,2020,1,0,BEFREE
4487,MSX1,0.525,0.731,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
4489,MT1A,0.537,0.808,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2008,2008,1,0,BEFREE
4508,ATP6,0.541,0.731,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
4513,COX2,0.352,0.962,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
4513,COX2,0.352,0.962,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
4513,COX2,0.352,0.962,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
4513,COX2,0.352,0.962,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
4513,COX2,0.352,0.962,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
4524,MTHFR,0.337,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,0,2006,2006,1,0,BEFREE
4582,MUC1,0.384,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
4594,MMUT,0.534,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
4594,MMUT,0.534,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
4602,MYB,0.49,0.692,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2013,2016,2,0,CTD_human
4602,MYB,0.49,0.692,C2363903,Angiocentric glioma,disease,,Neoplastic Process,0.31,1,2016,2016,1,0,BEFREE;ORPHANET
4603,MYBL1,0.705,0.308,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
4603,MYBL1,0.705,0.308,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2013,2013,1,0,CTD_human
4603,MYBL1,0.705,0.308,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
4605,MYBL2,0.59,0.538,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
4609,MYC,0.344,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
4609,MYC,0.344,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4609,MYC,0.344,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
4613,MYCN,0.454,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.07,1,1989,2016,7,0,BEFREE
4613,MYCN,0.454,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.06,1,1988,2016,6,0,BEFREE
4613,MYCN,0.454,0.808,C1517444,"Ganglioneuroblastoma, Intermixed",disease,C04,Neoplastic Process,0.02,1,2001,2017,2,0,BEFREE
4613,MYCN,0.454,0.808,C1517445,"Ganglioneuroblastoma, Nodular",disease,C04,Neoplastic Process,0.03,1,2001,2017,3,0,BEFREE
4613,MYCN,0.454,0.808,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.05,1,1988,2016,5,0,BEFREE
4638,MYLK,0.51,0.846,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,1999,1999,1,0,CTD_human
4645,MYO5B,0.641,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
4683,NBN,0.467,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
4683,NBN,0.467,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
4684,NCAM1,0.415,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.02,1,2008,2016,2,0,BEFREE;LHGDN
4684,NCAM1,0.415,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,LHGDN
4684,NCAM1,0.415,0.885,C0546275,Hypoganglionosis,disease,,Disease or Syndrome,0.01,1,2017,2017,1,0,BEFREE
4684,NCAM1,0.415,0.885,C1332562,Bladder Paraganglioma,disease,C04;C13;C12,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
4714,NDUFB8,0.638,0.654,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
4720,NDUFS2,0.601,0.654,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
4758,NEU1,0.513,0.769,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.04,1,2010,2015,4,0,BEFREE
4763,NF1,0.44,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.05,1,2006,2018,5,0,BEFREE
4763,NF1,0.44,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,1,CLINVAR
4763,NF1,0.44,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2014,2014,1,0,CTD_human
4763,NF1,0.44,0.885,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,1992,2013,10,0,CLINGEN
4763,NF1,0.44,0.885,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
4771,NF2,0.468,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
4771,NF2,0.468,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
4790,NFKB1,0.396,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4792,NFKBIA,0.487,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,2014,2014,1,0,ORPHANET
4792,NFKBIA,0.487,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
4803,NGF,0.391,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
4804,NGFR,0.477,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2020,2020,1,0,BEFREE
4811,NID1,0.631,0.577,C0013375,Dysganglionosis,disease,C16,Congenital Abnormality,0.01,1,1994,1994,1,0,BEFREE
4821,NKX2-2,0.678,0.269,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
4821,NKX2-2,0.678,0.269,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
4827,NM,0.473,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
4830,NME1,0.443,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
4837,NNMT,0.559,0.654,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
4842,NOS1,0.408,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
4842,NOS1,0.408,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4842,NOS1,0.408,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
4842,NOS1,0.408,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
4842,NOS1,0.408,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4842,NOS1,0.408,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4842,NOS1,0.408,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
4842,NOS1,0.408,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4843,NOS2,0.364,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
4843,NOS2,0.364,0.923,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4843,NOS2,0.364,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
4843,NOS2,0.364,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
4843,NOS2,0.364,0.923,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4843,NOS2,0.364,0.923,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4843,NOS2,0.364,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
4843,NOS2,0.364,0.923,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4851,NOTCH1,0.369,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
4851,NOTCH1,0.369,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
4852,NPY,0.447,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
4852,NPY,0.447,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
4852,NPY,0.447,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
4853,NOTCH2,0.441,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2009,2,0,BEFREE;LHGDN
4853,NOTCH2,0.441,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2009,2,0,BEFREE
4853,NOTCH2,0.441,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2009,2,0,BEFREE
4853,NOTCH2,0.441,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2009,2,0,BEFREE
4854,NOTCH3,0.435,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
4854,NOTCH3,0.435,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
4860,PNP,0.527,0.885,C0017083,Gangliosidoses,disease,C16;C18;C10,Disease or Syndrome,0.01,1,1983,1983,1,0,BEFREE
4864,NPC1,0.518,0.692,C0017083,Gangliosidoses,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2001,2001,1,0,BEFREE
4880,NPPC,0.568,0.769,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
4902,NRTN,0.686,0.538,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
4902,NRTN,0.686,0.538,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.02,1,2000,2001,2,0,BEFREE
4914,NTRK1,0.422,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.02,1,1993,1997,2,0,BEFREE
4914,NTRK1,0.422,0.808,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2008,2008,1,0,BEFREE
4914,NTRK1,0.422,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1997,1997,1,0,BEFREE
4914,NTRK1,0.422,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2014,2014,1,0,CTD_human
4914,NTRK1,0.422,0.808,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1997,1997,1,0,BEFREE
4914,NTRK1,0.422,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2018,2019,2,0,BEFREE
4915,NTRK2,0.479,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
4915,NTRK2,0.479,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2016,2018,2,0,BEFREE
4915,NTRK2,0.479,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
4915,NTRK2,0.479,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2014,2014,1,0,CTD_human
4915,NTRK2,0.479,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
4916,NTRK3,0.522,0.692,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2009,2009,1,0,BEFREE
4916,NTRK3,0.522,0.692,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2014,2014,1,0,CTD_human
4916,NTRK3,0.522,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
4929,NR4A2,0.529,0.846,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
5002,SLC22A18,0.595,0.692,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
5027,P2RX7,0.45,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
5037,PEBP1,0.5,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
5047,PAEP,0.43,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
5047,PAEP,0.43,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5071,PRKN,0.431,0.846,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
5077,PAX3,0.481,0.769,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2013,2013,1,0,BEFREE
5077,PAX3,0.481,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5077,PAX3,0.481,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5080,PAX6,0.45,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
5080,PAX6,0.45,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
5087,PBX1,0.534,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5111,PCNA,0.382,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5111,PCNA,0.382,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
5111,PCNA,0.382,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
5111,PCNA,0.382,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5111,PCNA,0.382,0.846,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
5111,PCNA,0.382,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
5111,PCNA,0.382,0.846,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5127,CDK16,0.636,0.577,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2014,2017,2,0,BEFREE
5133,PDCD1,0.402,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5133,PDCD1,0.402,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5140,PDE3B,0.659,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
5140,PDE3B,0.659,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
5143,PDE4C,0.805,0.154,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5143,PDE4C,0.805,0.154,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5154,PDGFA,0.533,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
5154,PDGFA,0.533,0.731,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
5154,PDGFA,0.533,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
5155,PDGFB,0.488,0.846,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
5155,PDGFB,0.488,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
5155,PDGFB,0.488,0.846,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
5155,PDGFB,0.488,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
5156,PDGFRA,0.415,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2000,2016,4,0,BEFREE
5156,PDGFRA,0.415,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
5156,PDGFRA,0.415,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.02,1,2005,2009,2,0,BEFREE;LHGDN
5156,PDGFRA,0.415,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
5156,PDGFRA,0.415,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
5156,PDGFRA,0.415,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
5156,PDGFRA,0.415,0.808,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5156,PDGFRA,0.415,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2000,2014,3,0,BEFREE
5156,PDGFRA,0.415,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2000,2016,4,0,BEFREE
5156,PDGFRA,0.415,0.808,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5156,PDGFRA,0.415,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.03,1,2010,2019,3,0,BEFREE
5159,PDGFRB,0.416,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5172,SLC26A4,0.507,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2013,2016,2,0,BEFREE
5175,PECAM1,0.426,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
5176,SERPINF1,0.46,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
5176,SERPINF1,0.46,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
5176,SERPINF1,0.46,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
5178,PEG3,0.61,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5178,PEG3,0.61,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5241,PGR,0.426,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2015,2018,2,0,BEFREE
5243,ABCB1,0.344,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
5243,ABCB1,0.344,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
5243,ABCB1,0.344,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
5265,SERPINA1,0.41,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2004,2019,2,0,BEFREE;LHGDN
5290,PIK3CA,0.292,0.923,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,1,BEFREE
5290,PIK3CA,0.292,0.923,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C1328402,Metastatic glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5290,PIK3CA,0.292,0.923,C4331262,Rosette-forming glioneuronal neoplasm,disease,,Neoplastic Process,0.11,1,2017,2017,1,1,BEFREE;CLINVAR
5290,PIK3CA,0.292,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2017,2017,2,0,BEFREE
5291,PIK3CB,0.322,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C1328402,Metastatic glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5291,PIK3CB,0.322,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2017,2017,2,0,BEFREE
5293,PIK3CD,0.319,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C1328402,Metastatic glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5293,PIK3CD,0.319,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2017,2017,2,0,BEFREE
5294,PIK3CG,0.32,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C1328402,Metastatic glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5294,PIK3CG,0.32,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2017,2017,2,0,BEFREE
5321,PLA2G4A,0.496,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
5321,PLA2G4A,0.496,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
5328,PLAU,0.425,0.923,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
5328,PLAU,0.425,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
5329,PLAUR,0.536,0.731,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
5340,PLG,0.389,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1992,1992,1,0,BEFREE
5340,PLG,0.389,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1992,1992,1,0,BEFREE
5340,PLG,0.389,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1992,1992,1,0,BEFREE
5340,PLG,0.389,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1992,1992,1,0,BEFREE
5347,PLK1,0.467,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2012,2012,1,0,CTD_human
5368,PNOC,0.603,0.577,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
5409,PNMT,0.653,0.538,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2015,2017,2,0,BEFREE
5422,POLA1,0.653,0.731,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5422,POLA1,0.653,0.731,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2018,2019,2,0,BEFREE
5422,POLA1,0.653,0.731,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5443,POMC,0.356,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5443,POMC,0.356,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,2,BEFREE
5447,POR,0.502,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,1998,1998,1,0,CTD_human
5453,POU3F1,0.711,0.462,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
5453,POU3F1,0.711,0.462,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
5453,POU3F1,0.711,0.462,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
5453,POU3F1,0.711,0.462,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
5455,POU3F3,0.682,0.615,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5460,POU5F1,0.441,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5465,PPARA,0.432,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2017,2019,2,0,BEFREE
5465,PPARA,0.432,0.885,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5468,PPARG,0.358,0.885,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.02,1,2014,2018,2,0,BEFREE
5468,PPARG,0.358,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,2000,2000,1,0,ORPHANET
5476,CTSA,0.619,0.731,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.04,1,2000,2012,4,0,BEFREE
5478,PPIA,0.51,0.769,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5519,PPP2R1B,0.678,0.423,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
5519,PPP2R1B,0.678,0.423,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
5539,PPY,0.663,0.308,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2015,2018,2,0,BEFREE
5568,PRKACG,0.644,0.654,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2014,2017,2,0,BEFREE
5578,PRKCA,0.44,0.846,C2985174,Papillary glioneuronal tumor,disease,,Neoplastic Process,0.04,1,2013,2019,4,0,BEFREE
5594,MAPK1,0.33,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
5594,MAPK1,0.33,0.923,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5594,MAPK1,0.33,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
5594,MAPK1,0.33,0.923,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5594,MAPK1,0.33,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2010,2017,2,0,BEFREE
5595,MAPK3,0.379,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
5609,MAP2K7,0.419,0.808,C0431112,Anaplastic ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5609,MAP2K7,0.419,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5609,MAP2K7,0.419,0.808,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5617,PRL,0.406,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5621,PRNP,0.445,0.923,C0520789,Progressive subcortical gliosis,disease,C01;C10,Disease or Syndrome,0.01,1,1995,1995,1,0,BEFREE
5621,PRNP,0.445,0.923,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
5641,LGMN,0.579,0.731,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5641,LGMN,0.579,0.731,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5649,RELN,0.515,0.731,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2002,2004,2,0,BEFREE
5670,PSG2,0.492,0.731,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
5686,PSMA5,0.674,0.538,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
5686,PSMA5,0.674,0.538,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
5715,PSMD9,0.435,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5715,PSMD9,0.435,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
5724,PTAFR,0.575,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5724,PTAFR,0.575,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5724,PTAFR,0.575,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5724,PTAFR,0.575,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5728,PTEN,0.305,0.923,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.05,1,2003,2019,5,0,BEFREE
5728,PTEN,0.305,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.07,0.714,1999,2018,7,0,BEFREE;LHGDN
5728,PTEN,0.305,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.3,NA,NA,NA,0,0,GENOMICS_ENGLAND
5728,PTEN,0.305,0.923,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5728,PTEN,0.305,0.923,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.02,1,2000,2015,2,1,BEFREE
5728,PTEN,0.305,0.923,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2002,2002,1,0,CTD_human
5728,PTEN,0.305,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2018,2,0,BEFREE
5728,PTEN,0.305,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2018,2,0,BEFREE
5728,PTEN,0.305,0.923,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5728,PTEN,0.305,0.923,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
5728,PTEN,0.305,0.923,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,1999,2014,5,0,BEFREE
5728,PTEN,0.305,0.923,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5728,PTEN,0.305,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.06,0.667,1999,2018,6,0,BEFREE
5728,PTEN,0.305,0.923,C1266181,Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos),disease,C04,Neoplastic Process,0.3,1,2003,2003,1,0,ORPHANET
5728,PTEN,0.305,0.923,C1272516,Small cell glioblastoma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5728,PTEN,0.305,0.923,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
5728,PTEN,0.305,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
5741,PTH,0.397,0.846,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.01,1,2006,2006,1,0,BEFREE
5742,PTGS1,0.46,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.2,1,1999,1999,1,0,RGD
5743,PTGS2,0.314,0.962,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2003,2004,2,0,BEFREE;LHGDN
5743,PTGS2,0.314,0.962,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
5743,PTGS2,0.314,0.962,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.2,1,1999,1999,1,0,RGD
5743,PTGS2,0.314,0.962,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.31,1,2003,2005,2,0,BEFREE;CTD_human
5743,PTGS2,0.314,0.962,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
5743,PTGS2,0.314,0.962,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
5743,PTGS2,0.314,0.962,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
5743,PTGS2,0.314,0.962,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5743,PTGS2,0.314,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5744,PTHLH,0.453,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5744,PTHLH,0.453,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
5764,PTN,0.515,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5764,PTN,0.515,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5771,PTPN2,0.538,0.692,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5777,PTPN6,0.485,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5777,PTPN6,0.485,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5777,PTPN6,0.485,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5777,PTPN6,0.485,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5781,PTPN11,0.385,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5803,PTPRZ1,0.623,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2008,2018,2,0,BEFREE;LHGDN
5803,PTPRZ1,0.623,0.615,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5803,PTPRZ1,0.623,0.615,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5803,PTPRZ1,0.623,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5817,PVR,0.51,0.769,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
5829,PXN,0.547,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5874,RAB27B,0.608,0.692,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
5874,RAB27B,0.608,0.692,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
5874,RAB27B,0.608,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
5879,RAC1,0.429,0.962,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
5879,RAC1,0.429,0.962,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
5879,RAC1,0.429,0.962,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
5879,RAC1,0.429,0.962,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
5879,RAC1,0.429,0.962,C1504559,Retinal gliosis,disease,,Disease or Syndrome,0.01,1,2019,2019,1,0,BEFREE
5894,RAF1,0.418,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2013,2013,1,0,CTD_human
5906,RAP1A,0.502,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
5915,RARB,0.478,0.846,C0546275,Hypoganglionosis,disease,,Disease or Syndrome,0.01,1,2019,2019,1,1,BEFREE
5921,RASA1,0.481,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
5921,RASA1,0.481,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
5925,RB1,0.444,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
5925,RB1,0.444,0.885,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,LHGDN
5925,RB1,0.444,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
5925,RB1,0.444,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5947,RBP1,0.565,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
5965,RECQL,0.615,0.615,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
5967,REG1A,0.467,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
5967,REG1A,0.467,0.846,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
5978,REST,0.535,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
5978,REST,0.535,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
5978,REST,0.535,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
5978,REST,0.535,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
5979,RET,0.392,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.14,1,1996,2006,4,0,BEFREE;HPO
5979,RET,0.392,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,0.897,2000,2019,29,1,BEFREE;LHGDN
5979,RET,0.392,0.885,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.02,1,1998,2000,2,0,BEFREE
5979,RET,0.392,0.885,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.4,1,1994,2017,15,3,BEFREE;CTD_human
5979,RET,0.392,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.11,1,1993,1993,1,0,BEFREE;HPO
5979,RET,0.392,0.885,C0334595,Ganglioneuromatosis,disease,C04,Neoplastic Process,0.04,1,1999,2019,4,1,BEFREE
5979,RET,0.392,0.885,C0345240,Total intestinal aganglionosis,disease,C16;C06,Congenital Abnormality,0.07,1,1997,2013,7,0,BEFREE
5979,RET,0.392,0.885,C0345245,Hyperganglionosis,disease,,Disease or Syndrome,0.01,1,2019,2019,1,1,BEFREE
5979,RET,0.392,0.885,C0546275,Hypoganglionosis,disease,,Disease or Syndrome,0.02,1,2001,2011,2,0,BEFREE
5979,RET,0.392,0.885,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,1994,1996,2,0,CTD_human
5979,RET,0.392,0.885,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.11,1,2010,2010,1,0,BEFREE;HPO
5979,RET,0.392,0.885,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.03,1,1998,2014,3,0,BEFREE
5979,RET,0.392,0.885,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,1993,2017,12,0,CLINGEN
5979,RET,0.392,0.885,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.42,1,1994,2019,8,4,BEFREE;CTD_human;GWASCAT
5979,RET,0.392,0.885,C4293671,Abnormality of enteric ganglion morphology,phenotype,,Anatomical Abnormality,0.1,NA,NA,NA,0,0,HPO
6098,ROS1,0.439,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
6098,ROS1,0.439,0.885,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
6098,ROS1,0.439,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
6198,RPS6KB1,0.511,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
6271,S100A1,0.421,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
6271,S100A1,0.421,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.05,0.8,2004,2019,5,0,BEFREE
6271,S100A1,0.421,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
6271,S100A1,0.421,0.846,C1332562,Bladder Paraganglioma,disease,C04;C13;C12,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
6275,S100A4,0.448,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6275,S100A4,0.448,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6285,S100B,0.383,0.923,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
6285,S100B,0.383,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.05,0.8,2004,2019,5,0,BEFREE
6285,S100B,0.383,0.923,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
6285,S100B,0.383,0.923,C1332562,Bladder Paraganglioma,disease,C04;C13;C12,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
6304,SATB1,0.525,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
6310,ATXN1,0.534,0.769,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
6311,ATXN2,0.482,0.808,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
6315,ATXN8OS,0.65,0.423,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
6347,CCL2,0.321,0.962,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,1995,1995,1,0,BEFREE
6352,CCL5,0.403,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
6362,CCL18,0.489,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
6376,CX3CL1,0.478,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
6376,CX3CL1,0.478,0.808,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.02,1,2000,2001,2,0,BEFREE
6389,SDHA,0.517,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.2,0.955,2005,2019,22,2,BEFREE;HPO
6389,SDHA,0.517,0.731,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6389,SDHA,0.517,0.731,C0334416,Parasympathetic paraganglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6389,SDHA,0.517,0.731,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.11,1,2017,2017,1,0,BEFREE;HPO
6389,SDHA,0.517,0.731,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.02,1,2001,2014,2,0,BEFREE
6389,SDHA,0.517,0.731,C1533592,Malignant Paraganglionic Neoplasm,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6389,SDHA,0.517,0.731,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.5,1,2005,2013,8,0,CLINGEN;GENOMICS_ENGLAND
6390,SDHB,0.474,0.846,C0007279,Carotid Body Paraganglioma,disease,C04,Neoplastic Process,0.08,1,2002,2018,8,2,BEFREE
6390,SDHB,0.474,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
6390,SDHB,0.474,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.7,0.983,2001,2020,180,4,BEFREE;CGI;CLINVAR;CTD_human;HPO;LHGDN
6390,SDHB,0.474,0.846,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.12,1,2009,2015,2,0,BEFREE;HPO
6390,SDHB,0.474,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
6390,SDHB,0.474,0.846,C1332851,Cardiac Paraganglioma,disease,C04;C14,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
6390,SDHB,0.474,0.846,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.2,1,2003,2020,12,1,BEFREE;HPO
6390,SDHB,0.474,0.846,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.4,0.909,2001,2014,11,0,BEFREE;GENOMICS_ENGLAND
6390,SDHB,0.474,0.846,C1533592,Malignant Paraganglionic Neoplasm,disease,C04,Neoplastic Process,0.07,1,2009,2019,7,2,BEFREE
6390,SDHB,0.474,0.846,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.43,1,2001,2019,55,52,BEFREE;CLINGEN;CLINVAR
6390,SDHB,0.474,0.846,C4524841,Metastatic Paraganglioma,disease,,Neoplastic Process,0.02,0.5,2016,2017,2,0,BEFREE
6391,SDHC,0.517,0.846,C0007279,Carotid Body Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
6391,SDHC,0.517,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.11,1,2016,2016,1,1,BEFREE;CLINVAR
6391,SDHC,0.517,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.5,1,1999,2019,56,5,BEFREE;CGI;CLINVAR;HPO;LHGDN
6391,SDHC,0.517,0.846,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.11,1,2012,2012,1,0,BEFREE;HPO
6391,SDHC,0.517,0.846,C0334415,Sympathetic paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6391,SDHC,0.517,0.846,C1332851,Cardiac Paraganglioma,disease,C04;C14,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
6391,SDHC,0.517,0.846,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.15,1,2003,2011,5,2,BEFREE;HPO
6391,SDHC,0.517,0.846,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.1,0.929,1999,2014,14,0,BEFREE
6391,SDHC,0.517,0.846,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.61,1,2000,2018,28,7,BEFREE;CLINGEN;CLINVAR;GENOMICS_ENGLAND
6392,SDHD,0.472,0.885,C0007279,Carotid Body Paraganglioma,disease,C04,Neoplastic Process,0.18,1,2001,2019,8,1,BEFREE;CLINVAR
6392,SDHD,0.472,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.8,0.994,1996,2020,154,14,BEFREE;CGI;CTD_human;GENOMICS_ENGLAND;HPO;LHGDN;UNIPROT
6392,SDHD,0.472,0.885,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.12,1,2009,2012,2,0,BEFREE;HPO
6392,SDHD,0.472,0.885,C0334416,Parasympathetic paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
6392,SDHD,0.472,0.885,C1332860,Cauda Equina Paraganglioma,disease,,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
6392,SDHD,0.472,0.885,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.2,0.941,1998,2018,17,3,BEFREE;HPO
6392,SDHD,0.472,0.885,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.1,0.966,2000,2018,29,1,BEFREE
6392,SDHD,0.472,0.885,C1533592,Malignant Paraganglionic Neoplasm,disease,C04,Neoplastic Process,0.02,1,2008,2012,2,1,BEFREE
6392,SDHD,0.472,0.885,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.6,1,1997,2015,32,16,CLINGEN;CLINVAR;GENOMICS_ENGLAND
6392,SDHD,0.472,0.885,C1866555,Glomus tympanicum paraganglioma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
6392,SDHD,0.472,0.885,C1868633,Paragangliomas with Sensorineural Hearing Loss,disease,C23;C04;C10;C09,Disease or Syndrome,0.1,1,2000,2016,57,41,CLINVAR
6392,SDHD,0.472,0.885,C4022005,Carotid paraganglioma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
6423,SFRP2,0.544,0.731,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
6445,SGCG,0.621,0.615,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2014,2014,1,0,BEFREE
6455,SH3GL1,0.686,0.346,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6495,SIX1,0.496,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
6505,SLC1A1,0.561,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6505,SLC1A1,0.561,0.654,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
6505,SLC1A1,0.561,0.654,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6505,SLC1A1,0.561,0.654,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6505,SLC1A1,0.561,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6513,SLC2A1,0.388,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
6513,SLC2A1,0.388,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
6513,SLC2A1,0.388,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
6513,SLC2A1,0.388,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6513,SLC2A1,0.388,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
6528,SLC5A5,0.499,0.769,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2003,2003,1,0,CTD_human
6530,SLC6A2,0.49,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.03,1,2012,2019,3,0,BEFREE
6530,SLC6A2,0.49,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
6548,SLC9A1,0.55,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6548,SLC9A1,0.55,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6548,SLC9A1,0.55,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6548,SLC9A1,0.55,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6571,SLC18A2,0.554,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2010,2012,2,0,BEFREE
6595,SMARCA2,0.527,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,1,BEFREE
6595,SMARCA2,0.527,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,1,BEFREE
6595,SMARCA2,0.527,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,1,BEFREE
6595,SMARCA2,0.527,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,1,BEFREE
6597,SMARCA4,0.45,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,2,BEFREE
6597,SMARCA4,0.45,0.885,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,2,BEFREE
6597,SMARCA4,0.45,0.885,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,2,BEFREE
6597,SMARCA4,0.45,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,2,BEFREE
6598,SMARCB1,0.434,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,LHGDN
6598,SMARCB1,0.434,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
6598,SMARCB1,0.434,0.846,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
6606,SMN1,0.454,0.769,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,1997,1997,1,0,BEFREE
6607,SMN2,0.459,0.769,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,1997,1997,1,0,BEFREE
6609,SMPD1,0.499,0.885,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2019,2019,1,0,BEFREE
6615,SNAI1,0.474,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6620,SNCB,0.619,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
6620,SNCB,0.619,0.577,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
6620,SNCB,0.619,0.577,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
6620,SNCB,0.619,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
6622,SNCA,0.427,0.885,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
6625,SNRNP70,0.595,0.692,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2012,2012,1,0,BEFREE
6638,SNRPN,0.538,0.731,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,1997,1997,1,0,BEFREE
6647,SOD1,0.379,0.962,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2002,2002,1,0,CTD_human
6647,SOD1,0.379,0.962,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,2001,2001,1,0,BEFREE
6647,SOD1,0.379,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
6652,SORD,0.552,0.769,C0007279,Carotid Body Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
6652,SORD,0.552,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,1,2003,2020,58,0,BEFREE
6652,SORD,0.552,0.769,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6652,SORD,0.552,0.769,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.06,1,2003,2020,6,0,BEFREE
6652,SORD,0.552,0.769,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.02,1,2011,2014,2,0,BEFREE
6652,SORD,0.552,0.769,C1533592,Malignant Paraganglionic Neoplasm,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6657,SOX2,0.405,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6657,SOX2,0.405,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.02,1,2010,2014,2,0,BEFREE
6657,SOX2,0.405,0.808,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6657,SOX2,0.405,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6657,SOX2,0.405,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6657,SOX2,0.405,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
6663,SOX10,0.461,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
6663,SOX10,0.461,0.808,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2001,2001,1,0,BEFREE
6663,SOX10,0.461,0.808,C0546275,Hypoganglionosis,disease,,Disease or Syndrome,0.01,1,2018,2018,1,0,BEFREE
6663,SOX10,0.461,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
6663,SOX10,0.461,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
6663,SOX10,0.461,0.808,C4023430,Long-segment aganglionic megacolon,disease,C16;C06,Congenital Abnormality,0.1,NA,NA,NA,0,0,HPO
6663,SOX10,0.461,0.808,C4289688,"Diffuse midline glioma, point mutation K27M in histone H3",disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
6696,SPP1,0.353,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2006,1,0,CTD_human
6750,SST,0.399,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,1997,1997,1,0,BEFREE
6750,SST,0.399,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2002,2017,2,0,BEFREE
6750,SST,0.399,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,1,2008,2019,17,0,BEFREE;LHGDN
6750,SST,0.399,0.885,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
6750,SST,0.399,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
6750,SST,0.399,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6750,SST,0.399,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2015,2018,2,0,BEFREE
6750,SST,0.399,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2002,2017,2,0,BEFREE
6750,SST,0.399,0.885,C1332562,Bladder Paraganglioma,disease,C04;C13;C12,Neoplastic Process,0.01,1,2020,2020,1,0,BEFREE
6750,SST,0.399,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6750,SST,0.399,0.885,C1533592,Malignant Paraganglionic Neoplasm,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
6752,SSTR2,0.539,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.31,1,2017,2017,2,0,BEFREE;CTD_human
6752,SSTR2,0.539,0.731,C4289979,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
6752,SSTR2,0.539,0.731,C4524841,Metastatic Paraganglioma,disease,,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
6770,STAR,0.513,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2003,2009,2,0,BEFREE
6770,STAR,0.513,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
6770,STAR,0.513,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
6770,STAR,0.513,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2003,2009,2,0,BEFREE
6774,STAT3,0.32,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
6774,STAT3,0.32,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2011,2012,2,0,BEFREE
6778,STAT6,0.475,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6781,STC1,0.532,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6783,SULT1E1,0.508,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
6783,SULT1E1,0.508,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
6783,SULT1E1,0.508,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
6783,SULT1E1,0.508,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
6790,AURKA,0.475,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6790,AURKA,0.475,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6794,STK11,0.435,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
6794,STK11,0.435,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
6822,SULT2A1,0.545,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
6822,SULT2A1,0.545,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
6822,SULT2A1,0.545,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
6822,SULT2A1,0.545,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
6834,SURF1,0.578,0.654,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
6853,SYN1,0.597,0.462,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
6853,SYN1,0.597,0.462,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,2012,2012,1,0,BEFREE
6853,SYN1,0.597,0.462,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
6855,SYP,0.481,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
6855,SYP,0.481,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2002,2019,5,0,BEFREE
6855,SYP,0.481,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2018,2019,2,0,BEFREE
6855,SYP,0.481,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
6855,SYP,0.481,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
6855,SYP,0.481,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
6855,SYP,0.481,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2002,2019,5,0,BEFREE
6855,SYP,0.481,0.808,C1332562,Bladder Paraganglioma,disease,C04;C13;C12,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
6863,TAC1,0.424,0.923,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
6867,TACC1,0.769,0.192,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,2012,2012,1,0,ORPHANET
6868,ADAM17,0.453,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
6900,CNTN2,0.581,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2015,2,0,BEFREE
6900,CNTN2,0.581,0.692,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6900,CNTN2,0.581,0.692,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6900,CNTN2,0.581,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2007,2015,2,0,BEFREE
6908,TBP,0.552,0.846,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
6925,TCF4,0.464,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6925,TCF4,0.464,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6929,TCF3,0.476,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
6929,TCF3,0.476,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
6929,TCF3,0.476,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
6934,TCF7L2,0.485,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6934,TCF7L2,0.485,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
6938,TCF12,0.565,0.654,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6938,TCF12,0.565,0.654,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6938,TCF12,0.565,0.654,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
6949,TCOF1,0.55,0.808,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2013,2013,1,0,BEFREE
6962,TRBV20OR9-2,0.403,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
7012,TERC,0.471,0.846,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.02,1,2014,2018,2,0,BEFREE
7012,TERC,0.471,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2014,2015,2,0,BEFREE
7015,TERT,0.374,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.07,1,2016,2019,7,0,BEFREE
7015,TERT,0.374,0.846,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2008,2009,2,0,CTD_human
7015,TERT,0.374,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2017,2019,3,0,BEFREE
7015,TERT,0.374,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2017,2019,3,0,BEFREE
7015,TERT,0.374,0.846,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
7015,TERT,0.374,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.07,1,2016,2019,7,0,BEFREE
7015,TERT,0.374,0.846,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2017,2018,2,0,BEFREE
7035,TFPI,0.486,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
7037,TFRC,0.437,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2006,1,0,CTD_human
7040,TGFB1,0.287,0.962,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.03,0.667,2009,2019,3,0,BEFREE
7042,TGFB2,0.433,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2011,2016,2,0,BEFREE
7045,TGFBI,0.484,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7054,TH,0.462,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7054,TH,0.462,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.05,1,2008,2018,5,0,BEFREE
7054,TH,0.462,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1993,2003,2,0,BEFREE
7054,TH,0.462,0.885,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
7057,THBS1,0.407,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
7057,THBS1,0.407,0.885,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
7057,THBS1,0.407,0.885,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
7070,THY1,0.496,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
7076,TIMP1,0.38,0.885,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
7079,TIMP4,0.559,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
7079,TIMP4,0.559,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
7080,NKX2-1,0.457,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7091,TLE4,0.674,0.462,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7091,TLE4,0.674,0.462,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7097,TLR2,0.361,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
7122,CLDN5,0.559,0.769,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,0,2018,2018,1,0,BEFREE
7124,TNF,0.231,0.962,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
7124,TNF,0.231,0.962,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2011,2011,1,0,CTD_human
7124,TNF,0.231,0.962,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
7124,TNF,0.231,0.962,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
7124,TNF,0.231,0.962,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
7124,TNF,0.231,0.962,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
7124,TNF,0.231,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2015,2019,2,0,BEFREE
7133,TNFRSF1B,0.425,0.885,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
7133,TNFRSF1B,0.425,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
7133,TNFRSF1B,0.425,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
7143,TNR,0.686,0.346,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
7143,TNR,0.686,0.346,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
7143,TNR,0.686,0.346,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
7153,TOP2A,0.497,0.731,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2008,2008,1,0,CTD_human
7157,TP53,0.236,0.962,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
7157,TP53,0.236,0.962,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.1,0.946,1993,2019,37,5,BEFREE;LHGDN
7157,TP53,0.236,0.962,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.31,1,2003,2003,1,0,BEFREE;GENOMICS_ENGLAND
7157,TP53,0.236,0.962,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2015,2015,1,0,BEFREE
7157,TP53,0.236,0.962,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.05,0.8,2001,2016,5,0,BEFREE;LHGDN
7157,TP53,0.236,0.962,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1998,2001,2,0,BEFREE
7157,TP53,0.236,0.962,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.35,1,1995,2017,6,0,BEFREE;ORPHANET
7157,TP53,0.236,0.962,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.51,1,2006,2014,5,0,BEFREE;CTD_human;CTD_mouse
7157,TP53,0.236,0.962,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.09,1,1997,2019,9,5,BEFREE
7157,TP53,0.236,0.962,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.09,1,1997,2019,9,5,BEFREE
7157,TP53,0.236,0.962,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2007,2019,3,0,BEFREE
7157,TP53,0.236,0.962,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.06,0.833,2002,2019,6,1,BEFREE
7157,TP53,0.236,0.962,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.08,1,1998,2019,8,1,BEFREE
7157,TP53,0.236,0.962,C0431112,Anaplastic ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
7157,TP53,0.236,0.962,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.1,0.946,1993,2019,37,5,BEFREE
7157,TP53,0.236,0.962,C1321878,Desmoplastic infantile ganglioglioma,disease,,Neoplastic Process,0.02,1,1992,2014,2,0,BEFREE
7157,TP53,0.236,0.962,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2007,2019,3,0,BEFREE
7157,TP53,0.236,0.962,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.04,0.75,2003,2016,4,0,BEFREE
7157,TP53,0.236,0.962,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.02,1,2014,2015,2,0,BEFREE
7157,TP53,0.236,0.962,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,1995,2006,2,0,BEFREE
7157,TP53,0.236,0.962,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.02,1,1998,2001,2,0,BEFREE
7157,TP53,0.236,0.962,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7157,TP53,0.236,0.962,C4329735,Diffuse leptomeningeal glioneuronal neoplasm,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
7157,TP53,0.236,0.962,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.06,1,2003,2019,6,0,BEFREE
7157,TP53,0.236,0.962,C4757951,Desmoplastic infantile astrocytoma and ganglioglioma,disease,,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
7161,TP73,0.449,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.06,0.833,1998,2011,6,0,BEFREE
7161,TP73,0.449,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
7161,TP73,0.449,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
7161,TP73,0.449,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.06,0.833,1998,2011,6,0,BEFREE
7170,TPM3,0.49,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7180,CRISP2,0.512,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
7180,CRISP2,0.512,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
7180,CRISP2,0.512,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
7190,HSP90B2P,0.558,0.846,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2016,2016,1,0,BEFREE
7248,TSC1,0.44,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2001,2018,2,0,BEFREE
7248,TSC1,0.44,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7249,TSC2,0.439,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.06,1,1997,2011,6,0,BEFREE
7249,TSC2,0.439,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2001,2002,2,0,BEFREE
7268,TTC4,0.691,0.385,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
7276,TTR,0.423,0.885,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,1990,1990,1,0,BEFREE
7291,TWIST1,0.397,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
7293,TNFRSF4,0.547,0.692,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7297,TYK2,0.505,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
7297,TYK2,0.505,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
7297,TYK2,0.505,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
7297,TYK2,0.505,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
7305,TYROBP,0.573,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
7305,TYROBP,0.573,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
7329,UBE2I,0.544,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
7329,UBE2I,0.544,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
7334,UBE2N,0.593,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
7345,UCHL1,0.482,0.885,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7345,UCHL1,0.482,0.885,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7345,UCHL1,0.482,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
7368,UGT8,0.636,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
7368,UGT8,0.636,0.615,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,2003,2003,1,0,BEFREE
7368,UGT8,0.636,0.615,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
7368,UGT8,0.636,0.615,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
7368,UGT8,0.636,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
7412,VCAM1,0.422,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
7422,VEGFA,0.266,0.923,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
7422,VEGFA,0.266,0.923,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1998,2017,2,0,BEFREE
7422,VEGFA,0.266,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.05,1,2000,2017,5,0,BEFREE
7422,VEGFA,0.266,0.923,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.31,1,1999,2006,2,0,BEFREE;CTD_human
7422,VEGFA,0.266,0.923,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1998,2017,2,0,BEFREE
7422,VEGFA,0.266,0.923,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1998,2017,2,0,BEFREE
7422,VEGFA,0.266,0.923,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1998,2014,2,0,BEFREE
7422,VEGFA,0.266,0.923,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1998,2017,2,0,BEFREE
7422,VEGFA,0.266,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
7422,VEGFA,0.266,0.923,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.06,1,2014,2019,6,0,BEFREE
7422,VEGFA,0.266,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.03,1,2009,2018,3,0,BEFREE
7424,VEGFC,0.459,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,0,2012,2012,1,0,BEFREE
7428,VHL,0.443,0.846,C0007279,Carotid Body Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,1,BEFREE
7428,VHL,0.443,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.5,1,2002,2020,39,1,BEFREE;GENOMICS_ENGLAND;HPO;LHGDN
7428,VHL,0.443,0.846,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.11,1,2013,2013,1,0,BEFREE;HPO
7428,VHL,0.443,0.846,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
7428,VHL,0.443,0.846,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,1991,2011,12,0,CLINGEN
7431,VIM,0.372,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
7431,VIM,0.372,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
7431,VIM,0.372,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
7431,VIM,0.372,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1994,1994,1,0,BEFREE
7431,VIM,0.372,0.846,C1504559,Retinal gliosis,disease,,Disease or Syndrome,0.01,1,2010,2010,1,0,BEFREE
7432,VIP,0.437,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
7432,VIP,0.437,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,1993,1993,1,0,BEFREE
7443,VRK1,0.621,0.615,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
7444,VRK2,0.722,0.269,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.1,1,2016,2016,1,1,GWASCAT
7448,VTN,0.509,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,1997,1997,1,0,BEFREE
7465,WEE1,0.545,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7490,WT1,0.422,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
7494,XBP1,0.477,0.846,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2011,2011,1,0,CTD_human
7514,XPO1,0.504,0.692,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2017,2017,1,0,BEFREE
7514,XPO1,0.504,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2020,2020,1,0,BEFREE
7515,XRCC1,0.421,0.923,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2014,2014,1,0,CTD_human
7535,ZAP70,0.497,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
7535,ZAP70,0.497,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
7535,ZAP70,0.497,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
7535,ZAP70,0.497,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
7786,MAP3K12,0.7,0.346,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
7799,PRDM2,0.545,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
7799,PRDM2,0.545,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
7799,PRDM2,0.545,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
7799,PRDM2,0.545,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
7832,BTG2,0.587,0.538,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
7832,BTG2,0.587,0.538,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
7832,BTG2,0.587,0.538,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
7832,BTG2,0.587,0.538,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
7852,CXCR4,0.362,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
7852,CXCR4,0.362,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
7975,MAFK,0.592,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
7975,MAFK,0.592,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
7980,TFPI2,0.521,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
7991,TUSC3,0.576,0.615,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
8022,LHX3,0.644,0.462,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8022,LHX3,0.644,0.462,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8022,LHX3,0.644,0.462,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8022,LHX3,0.644,0.462,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8038,ADAM12,0.565,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
8038,ADAM12,0.565,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
8048,CSRP3,0.572,0.731,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
8085,KMT2D,0.465,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
8085,KMT2D,0.465,0.808,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2015,2015,1,0,CLINGEN
8089,YEATS4,0.666,0.231,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,1997,1997,1,0,BEFREE
8111,GPR68,0.65,0.462,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8163,CDR3,0.472,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2020,2020,1,0,BEFREE
8216,LZTR1,0.547,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,2013,2013,2,0,ORPHANET
8239,USP9X,0.502,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
8290,H3-4,0.711,0.538,C4289688,"Diffuse midline glioma, point mutation K27M in histone H3",disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8314,BAP1,0.454,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.33,1,2012,2019,4,0,BEFREE;CTD_human
8314,BAP1,0.454,0.731,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2012,2012,1,0,CLINGEN
8350,H3C1,0.67,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8350,H3C1,0.67,0.308,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8350,H3C1,0.67,0.308,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8350,H3C1,0.67,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8351,H3C4,0.67,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8351,H3C4,0.67,0.308,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8351,H3C4,0.67,0.308,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8351,H3C4,0.67,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8352,H3C3,0.67,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8352,H3C3,0.67,0.308,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8352,H3C3,0.67,0.308,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8352,H3C3,0.67,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8353,H3C6,0.666,0.346,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8353,H3C6,0.666,0.346,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8353,H3C6,0.666,0.346,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8353,H3C6,0.666,0.346,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8354,H3C11,0.663,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8354,H3C11,0.663,0.308,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8354,H3C11,0.663,0.308,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8354,H3C11,0.663,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8355,H3C8,0.67,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8355,H3C8,0.67,0.308,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8355,H3C8,0.67,0.308,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8355,H3C8,0.67,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8356,H3C12,0.666,0.385,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8356,H3C12,0.666,0.385,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8356,H3C12,0.666,0.385,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8356,H3C12,0.666,0.385,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8357,H3C10,0.67,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8357,H3C10,0.67,0.308,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8357,H3C10,0.67,0.308,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8357,H3C10,0.67,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8358,H3C2,0.653,0.423,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8358,H3C2,0.653,0.423,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2012,2012,1,0,CTD_human
8358,H3C2,0.653,0.423,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8358,H3C2,0.653,0.423,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8358,H3C2,0.653,0.423,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8398,PLA2G6,0.476,0.846,C4022768,Cerebellar gliosis,phenotype,C23,Anatomical Abnormality,0.1,NA,NA,NA,0,1,CLINVAR
8402,SLC25A11,0.666,0.615,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
8402,SLC25A11,0.666,0.615,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
8408,ULK1,0.564,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8436,CAVIN2,0.617,0.615,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2015,2015,1,0,CTD_human
8436,CAVIN2,0.617,0.615,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2015,2015,1,0,CTD_human
8436,CAVIN2,0.617,0.615,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2015,2015,1,0,CTD_human
8438,RAD54L,0.633,0.423,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
8438,RAD54L,0.633,0.423,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
8452,CUL3,0.592,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
8452,CUL3,0.592,0.654,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
8452,CUL3,0.592,0.654,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
8452,CUL3,0.592,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
8493,PPM1D,0.513,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2014,2014,1,0,CTD_human
8506,CNTNAP1,0.554,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
8506,CNTNAP1,0.554,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
8570,KHSRP,0.526,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
8570,KHSRP,0.526,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
8570,KHSRP,0.526,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
8605,PLA2G4C,0.705,0.385,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
8605,PLA2G4C,0.705,0.385,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
8622,PDE8B,0.638,0.5,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
8624,PSMG1,0.579,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
8624,PSMG1,0.579,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
8643,PTCH2,0.563,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
8643,PTCH2,0.563,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
8678,BECN1,0.432,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8678,BECN1,0.432,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
8682,PEA15,0.553,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
8725,URI1,0.633,0.654,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
8743,TNFSF10,0.413,0.885,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2009,2,0,CTD_human
8743,TNFSF10,0.413,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.03,1,2007,2011,3,0,BEFREE
8771,TNFRSF6B,0.528,0.731,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
8772,FADD,0.537,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.2,1,2017,2017,1,0,RGD
8788,DLK1,0.527,0.692,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
8797,TNFRSF10A,0.521,0.731,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
8842,PROM1,0.41,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2013,2015,2,0,BEFREE
8842,PROM1,0.41,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,0,2010,2010,1,0,BEFREE
8842,PROM1,0.41,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8842,PROM1,0.41,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8842,PROM1,0.41,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8848,TSC22D1,0.619,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
8848,TSC22D1,0.619,0.615,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
8848,TSC22D1,0.619,0.615,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
8848,TSC22D1,0.619,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
8851,CDK5R1,0.529,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE;LHGDN
8880,FUBP1,0.61,0.615,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8880,FUBP1,0.61,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.08,1,2011,2015,8,0,BEFREE
8880,FUBP1,0.61,0.615,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8880,FUBP1,0.61,0.615,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2011,2015,3,0,BEFREE
8880,FUBP1,0.61,0.615,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2011,2015,3,0,BEFREE
8880,FUBP1,0.61,0.615,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2012,2017,2,0,BEFREE
8880,FUBP1,0.61,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.08,1,2011,2015,8,0,BEFREE
8880,FUBP1,0.61,0.615,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
8926,SNURF,0.623,0.538,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.01,1,1997,1997,1,0,BEFREE
8929,PHOX2B,0.565,0.731,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.11,1,2018,2018,1,0,BEFREE;HPO
8929,PHOX2B,0.565,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
8929,PHOX2B,0.565,0.731,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2007,2007,1,0,BEFREE
8929,PHOX2B,0.565,0.731,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.11,1,2005,2005,1,0,BEFREE;HPO
8929,PHOX2B,0.565,0.731,C1517444,"Ganglioneuroblastoma, Intermixed",disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
8929,PHOX2B,0.565,0.731,C2751683,Hirschsprung disease ganglioneuroblastoma,disease,C16;C06;C04,Disease or Syndrome,0.6,1,2017,2017,1,1,CLINVAR;GENOMICS_ENGLAND;ORPHANET
8929,PHOX2B,0.565,0.731,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
8968,H3C7,0.67,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8968,H3C7,0.67,0.308,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8968,H3C7,0.67,0.308,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
8968,H3C7,0.67,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
9020,MAP3K14,0.608,0.769,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2014,2017,2,0,BEFREE
9048,ARTN,0.48,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
9049,AIP,0.517,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
9077,DIRAS3,0.631,0.385,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
9077,DIRAS3,0.631,0.385,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
9112,MTA1,0.547,0.692,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
9118,INA,0.633,0.5,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2004,2013,4,0,BEFREE
9118,INA,0.633,0.5,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2004,2013,2,0,BEFREE
9118,INA,0.633,0.5,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2004,2013,2,0,BEFREE
9118,INA,0.633,0.5,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2004,2013,4,0,BEFREE
9131,AIFM1,0.527,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
9211,LGI1,0.568,0.731,C4706583,Limbic encephalitis with leucine-rich glioma-inactivated 1 antibodies,disease,C04;C01;C10;C19,Disease or Syndrome,0.01,1,2017,2017,1,0,BEFREE
9360,PPIG,0.497,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
9361,LONP1,0.517,0.808,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9409,PEX16,0.597,0.615,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2016,2016,1,0,BEFREE
9444,QKI,0.617,0.5,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9444,QKI,0.617,0.5,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2016,2016,1,0,CTD_human
9444,QKI,0.617,0.5,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9444,QKI,0.617,0.5,C2363903,Angiocentric glioma,disease,,Neoplastic Process,0.31,1,2016,2016,1,0,BEFREE;ORPHANET
9447,AIM2,0.521,0.769,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
9477,MED20,0.861,0.077,C0854279,Basal ganglion degeneration,disease,,Disease or Syndrome,0.01,1,2015,2015,1,2,BEFREE
9493,KIF23,0.682,0.385,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
9518,GDF15,0.429,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
9518,GDF15,0.429,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
9518,GDF15,0.429,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
9518,GDF15,0.429,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
9521,EEF1E1,0.59,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
9521,EEF1E1,0.59,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
9545,RAB3D,0.682,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9545,RAB3D,0.682,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9547,CXCL14,0.554,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
9588,PRDX6,0.572,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,LHGDN
9627,SNCAIP,0.691,0.423,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
9628,RGS6,0.564,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
9628,RGS6,0.564,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
9699,RIMS2,0.769,0.423,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
9699,RIMS2,0.769,0.423,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
9699,RIMS2,0.769,0.423,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
9699,RIMS2,0.769,0.423,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
9722,NOS1AP,0.608,0.423,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
9780,PIEZO1,0.552,0.769,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1999,1999,1,0,BEFREE
9790,BMS1,0.499,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
9833,MELK,0.566,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
9833,MELK,0.566,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
9833,MELK,0.566,0.577,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
9860,LRIG2,0.666,0.423,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9860,LRIG2,0.666,0.423,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9860,LRIG2,0.666,0.423,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9860,LRIG2,0.666,0.423,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
9874,TLK1,0.641,0.577,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2014,2017,2,0,BEFREE
9907,AP5Z1,0.7,0.346,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
9907,AP5Z1,0.7,0.346,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
9961,MVP,0.512,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE;LHGDN
9965,FGF19,0.548,0.615,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.01,1,1999,1999,1,0,BEFREE
9997,SCO2,0.479,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
9997,SCO2,0.479,0.846,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
10000,AKT3,0.512,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
10018,BCL2L11,0.51,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
10085,EDIL3,0.564,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
10085,EDIL3,0.564,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
10131,TRAP1,0.59,0.615,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
10168,ZNF197,0.606,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
10168,ZNF197,0.606,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
10178,TENM1,0.653,0.692,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
10186,LHFPL6,0.705,0.462,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
10205,MPZL2,0.653,0.5,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2013,2016,2,0,BEFREE
10215,OLIG2,0.56,0.577,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,1,BEFREE
10215,OLIG2,0.56,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.1,1,2001,2018,13,1,BEFREE;LHGDN
10215,OLIG2,0.56,0.577,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2013,2,1,BEFREE
10215,OLIG2,0.56,0.577,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2013,2,1,BEFREE
10215,OLIG2,0.56,0.577,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2003,2004,2,0,BEFREE
10215,OLIG2,0.56,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.1,1,2001,2018,12,1,BEFREE
10253,SPRY2,0.554,0.654,C0345245,Hyperganglionosis,disease,,Disease or Syndrome,0.01,1,2009,2009,1,0,BEFREE
10278,EFS,0.597,0.615,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
10309,CCNO,0.621,0.538,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
10309,CCNO,0.621,0.538,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
10309,CCNO,0.621,0.538,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
10309,CCNO,0.621,0.538,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
10309,CCNO,0.621,0.538,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.03,1,2013,2016,3,0,BEFREE
10309,CCNO,0.621,0.538,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
10309,CCNO,0.621,0.538,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
10309,CCNO,0.621,0.538,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
10309,CCNO,0.621,0.538,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
10312,TCIRG1,0.565,0.692,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.01,1,2002,2002,1,0,BEFREE
10381,TUBB3,0.486,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2002,2002,1,0,BEFREE
10381,TUBB3,0.486,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2002,2002,1,0,BEFREE
10403,NDC80,0.599,0.538,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
10403,NDC80,0.599,0.538,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
10413,YAP1,0.432,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
10413,YAP1,0.432,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
10451,VAV3,0.603,0.615,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
10460,TACC3,0.615,0.615,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,2012,2012,1,0,ORPHANET
10461,MERTK,0.531,0.692,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
10461,MERTK,0.531,0.692,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2016,2016,1,0,CLINGEN
10512,SEMA3C,0.619,0.731,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2015,2015,1,0,ORPHANET
10519,CIB1,0.458,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,2010,2,0,BEFREE
10519,CIB1,0.458,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,2010,2,0,BEFREE
10534,ZNRD2,0.443,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
10534,ZNRD2,0.443,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
10573,MRPL28,0.505,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
10573,MRPL28,0.505,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
10573,MRPL28,0.505,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
10573,MRPL28,0.505,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
10608,MXD4,0.722,0.115,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2000,2000,1,0,BEFREE
10608,MXD4,0.722,0.115,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2000,2000,1,0,BEFREE
10608,MXD4,0.722,0.115,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2000,2000,1,0,BEFREE
10608,MXD4,0.722,0.115,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2000,2000,1,0,BEFREE
10611,PDLIM5,0.525,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
10611,PDLIM5,0.525,0.808,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
10630,PDPN,0.47,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
10643,IGF2BP3,0.57,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
10643,IGF2BP3,0.57,0.577,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
10643,IGF2BP3,0.57,0.577,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
10643,IGF2BP3,0.57,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
10671,DCTN6,0.442,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
10671,DCTN6,0.442,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
10682,EBP,0.494,0.846,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
10724,OGA,0.534,0.731,C0017083,Gangliosidoses,disease,C16;C18;C10,Disease or Syndrome,0.03,1,1996,2001,3,0,BEFREE
10724,OGA,0.534,0.731,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.1,1,1975,2016,25,0,BEFREE
10724,OGA,0.534,0.731,C0268278,Infantile GM 2 gangliosidosis,disease,C16;C18;C10,Disease or Syndrome,0.01,1,1985,1985,1,0,BEFREE
10724,OGA,0.534,0.731,C2749283,"Gm2-Gangliosidosis, Variant B1",disease,C16;C18;C10,Disease or Syndrome,0.07,1,1988,2003,7,0,BEFREE
10763,NES,0.45,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1995,1995,1,0,BEFREE
10763,NES,0.45,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
10763,NES,0.45,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1995,1995,1,0,BEFREE
10763,NES,0.45,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1995,1995,1,0,BEFREE
10763,NES,0.45,0.808,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
10763,NES,0.45,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1995,1995,1,0,BEFREE
10763,NES,0.45,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
10763,NES,0.45,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2018,2019,2,0,BEFREE
10777,ARPP21,0.663,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
10777,ARPP21,0.663,0.654,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
10777,ARPP21,0.663,0.654,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
10777,ARPP21,0.663,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
10791,VAMP5,0.821,0.154,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2016,2016,1,2,BEFREE
10810,WASF3,0.595,0.769,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
10810,WASF3,0.595,0.769,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
10848,PPP1R13L,0.539,0.692,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
10855,HPSE,0.425,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
10855,HPSE,0.425,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
10855,HPSE,0.425,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
10855,HPSE,0.425,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
10855,HPSE,0.425,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
10911,UTS2,0.564,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
10911,UTS2,0.564,0.808,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
10923,SUB1,0.465,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
10923,SUB1,0.465,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
10923,SUB1,0.465,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
10923,SUB1,0.465,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
10993,SDS,0.534,0.769,C0007279,Carotid Body Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
10993,SDS,0.534,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,1,2003,2020,58,0,BEFREE
10993,SDS,0.534,0.769,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
10993,SDS,0.534,0.769,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.06,1,2003,2020,6,0,BEFREE
10993,SDS,0.534,0.769,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.02,1,2011,2014,2,0,BEFREE
10993,SDS,0.534,0.769,C1533592,Malignant Paraganglionic Neoplasm,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
11010,GLIPR1,0.636,0.5,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
11051,NUDT21,0.682,0.231,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
11051,NUDT21,0.682,0.231,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
11060,WWP2,0.65,0.615,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
11148,HHLA2,0.653,0.423,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
11168,PSIP1,0.49,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
11168,PSIP1,0.49,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
11168,PSIP1,0.49,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
11170,FAM107A,0.674,0.462,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2006,1,0,CTD_human
11186,RASSF1,0.42,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
22858,CILK1,0.545,0.808,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2014,2017,2,0,BEFREE
22918,CD93,0.663,0.5,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
23028,KDM1A,0.512,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
23028,KDM1A,0.512,0.808,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
23040,MYT1L,0.659,0.462,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
23040,MYT1L,0.659,0.462,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
23040,MYT1L,0.659,0.462,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
23040,MYT1L,0.659,0.462,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
23095,KIF1B,0.516,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
23095,KIF1B,0.516,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
23095,KIF1B,0.516,0.808,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
23095,KIF1B,0.516,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
23095,KIF1B,0.516,0.808,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
23095,KIF1B,0.516,0.808,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2008,2014,5,0,CLINGEN
23135,KDM6B,0.514,0.808,C1328402,Metastatic glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
23135,KDM6B,0.514,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
23152,CIC,0.523,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.1,1,2011,2018,11,0,BEFREE
23152,CIC,0.523,0.692,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.07,1,2011,2017,7,0,BEFREE
23152,CIC,0.523,0.692,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.07,1,2011,2017,7,0,BEFREE
23152,CIC,0.523,0.692,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
23152,CIC,0.523,0.692,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.11,1,2012,2012,1,1,BEFREE;CLINVAR
23152,CIC,0.523,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.2,1,2011,2018,11,1,BEFREE;CLINVAR
23158,TBC1D9,0.399,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
23187,PHLDB1,0.722,0.423,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
23189,KANK1,0.641,0.538,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
23236,PLCB1,0.595,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
23236,PLCB1,0.595,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
23236,PLCB1,0.595,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2016,2019,2,0,BEFREE
23259,DDHD2,0.695,0.577,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2016,2016,1,0,BEFREE
23362,PSD3,0.691,0.423,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2006,2006,1,0,CTD_human
23406,COTL1,0.615,0.538,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
23429,RYBP,0.686,0.269,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
23429,RYBP,0.686,0.269,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
23435,TARDBP,0.493,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
23446,SLC44A1,0.695,0.346,C2985174,Papillary glioneuronal tumor,disease,,Neoplastic Process,0.03,1,2013,2019,3,0,BEFREE
23462,HEY1,0.551,0.692,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
23462,HEY1,0.551,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
23462,HEY1,0.551,0.692,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
23462,HEY1,0.551,0.692,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
23462,HEY1,0.551,0.692,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
23462,HEY1,0.551,0.692,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
23462,HEY1,0.551,0.692,C0751395,Mixed Oligodendroglioma-Ependymoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
23462,HEY1,0.551,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
23463,ICMT,0.682,0.423,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
23479,ISCU,0.695,0.423,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.02,1,2012,2018,2,0,BEFREE
23492,CBX7,0.595,0.615,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
23512,SUZ12,0.529,0.577,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2014,2014,1,0,CTD_human
23554,TSPAN12,0.656,0.5,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.01,1,2016,2016,1,0,BEFREE
23569,PADI4,0.494,0.808,C1504559,Retinal gliosis,disease,,Disease or Syndrome,0.01,1,2017,2017,1,0,BEFREE
23583,SMUG1,0.322,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.05,1,2017,2019,5,0,BEFREE
23583,SMUG1,0.322,0.923,C0334415,Sympathetic paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
23583,SMUG1,0.322,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
23591,FAM215A,0.65,0.5,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
23598,PATZ1,0.647,0.423,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
23636,NUP62,0.47,0.885,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
23650,TRIM29,0.606,0.654,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2019,2019,1,0,CTD_human
23705,CADM1,0.491,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
24137,KIF4A,0.647,0.462,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
25793,FBXO7,0.65,0.769,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
25859,PART1,0.483,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
25913,POT1,0.56,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.31,1,2015,2015,1,0,BEFREE;ORPHANET
25913,POT1,0.56,0.731,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,NA,NA,NA,0,0,CTD_human
25913,POT1,0.56,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
25913,POT1,0.56,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
25913,POT1,0.56,0.731,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2015,2015,1,0,ORPHANET
25913,POT1,0.56,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
25915,NDUFAF3,0.65,0.577,C2750915,Basal ganglia gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
25937,WWTR1,0.529,0.615,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
26018,LRIG1,0.601,0.538,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
26018,LRIG1,0.601,0.538,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
26018,LRIG1,0.601,0.538,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
26018,LRIG1,0.601,0.538,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
26047,CNTNAP2,0.53,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
26047,CNTNAP2,0.53,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
26291,FGF21,0.485,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
26292,MYCBP,0.663,0.5,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
26524,LATS2,0.554,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
26524,LATS2,0.554,0.654,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
26524,LATS2,0.554,0.654,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
26524,LATS2,0.554,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
27030,MLH3,0.582,0.538,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
27036,SIGLEC7,0.535,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
27036,SIGLEC7,0.535,0.846,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
27036,SIGLEC7,0.535,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
27040,LAT,0.548,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
27042,UTP25,0.805,0.269,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2014,2014,1,0,CTD_human
27042,UTP25,0.805,0.269,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2014,2014,1,0,CTD_human
27042,UTP25,0.805,0.269,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2014,2014,1,0,CTD_human
27063,ANKRD1,0.628,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
27063,ANKRD1,0.628,0.692,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
27122,DKK3,0.5,0.731,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,LHGDN
27165,GLS2,0.597,0.538,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
27165,GLS2,0.597,0.538,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
27165,GLS2,0.597,0.538,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
27165,GLS2,0.597,0.538,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
27165,GLS2,0.597,0.538,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
27165,GLS2,0.597,0.538,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
27237,ARHGEF16,0.931,0.038,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
27237,ARHGEF16,0.931,0.038,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
27239,GPR162,0.631,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
27239,GPR162,0.631,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
27338,UBE2S,0.653,0.5,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
27338,UBE2S,0.653,0.5,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
27342,RABGEF1,0.55,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
27346,TMEM97,0.604,0.615,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
27352,SGSM3,0.469,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2014,2018,2,0,BEFREE
27352,SGSM3,0.469,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.02,1,2014,2018,2,0,BEFREE
28987,NOB1,0.633,0.423,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
29107,NXT1,0.505,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
29107,NXT1,0.505,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
29107,NXT1,0.505,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
29107,NXT1,0.505,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
29126,CD274,0.324,0.923,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
29126,CD274,0.324,0.923,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
29126,CD274,0.324,0.923,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
29997,NOP53,0.597,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
29997,NOP53,0.597,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
29998,BICRA,0.695,0.269,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2018,2,1,BEFREE;LHGDN
29998,BICRA,0.695,0.269,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2018,2,0,BEFREE
29998,BICRA,0.695,0.269,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2018,2,0,BEFREE
29998,BICRA,0.695,0.269,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2005,2018,2,1,BEFREE
30833,NT5C,0.729,0.231,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
30833,NT5C,0.729,0.231,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
30833,NT5C,0.729,0.231,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
30833,NT5C,0.729,0.231,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
50940,PDE11A,0.612,0.654,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
50943,FOXP3,0.368,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2020,2020,1,0,BEFREE
50943,FOXP3,0.368,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2020,2020,1,0,BEFREE
50964,SOST,0.474,0.808,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.02,1,2015,2017,2,0,BEFREE
51014,TMED7,0.436,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
51014,TMED7,0.436,0.808,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
51083,GAL,0.493,0.846,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
51330,TNFRSF12A,0.509,0.692,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
51352,WT1-AS,0.597,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
51352,WT1-AS,0.597,0.615,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
51352,WT1-AS,0.597,0.615,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
51352,WT1-AS,0.597,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
51364,ZMYND10,0.553,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
51374,ATRAID,0.601,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
51374,ATRAID,0.601,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
51561,IL23A,0.415,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
51561,IL23A,0.415,0.846,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
51750,RTEL1,0.459,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2009,2009,2,0,CTD_human
51750,RTEL1,0.459,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
51809,GALNT7,0.736,0.308,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
51816,ADA2,0.545,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
54106,TLR9,0.411,0.885,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
54386,TERF2IP,0.548,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
54413,NLGN3,0.653,0.462,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
54454,ATAD2B,0.76,0.192,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
54454,ATAD2B,0.76,0.192,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
54454,ATAD2B,0.76,0.192,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
54454,ATAD2B,0.76,0.192,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
54583,EGLN1,0.54,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.38,1,2007,2019,9,0,BEFREE;GENOMICS_ENGLAND
54583,EGLN1,0.54,0.731,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.01,0,2012,2012,1,0,BEFREE
54583,EGLN1,0.54,0.731,C1533592,Malignant Paraganglionic Neoplasm,disease,C04,Neoplastic Process,0.01,0,2012,2012,1,0,BEFREE
54583,EGLN1,0.54,0.731,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2006,2015,6,0,CLINGEN
54658,UGT1A1,0.464,0.769,C0338329,recurrent childhood brain stem glioma,disease,,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
54704,PDP1,0.691,0.462,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
54739,XAF1,0.587,0.769,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2017,2017,1,0,CTD_human
54840,APTX,0.59,0.5,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
54840,APTX,0.59,0.5,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2013,2013,2,0,BEFREE
54840,APTX,0.59,0.5,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
54880,BCOR,0.471,0.808,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2015,2015,1,0,BEFREE
54949,SDHAF2,0.604,0.692,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.4,1,2005,2019,24,0,BEFREE;CGI
54949,SDHAF2,0.604,0.692,C0030422,Extra-Adrenal Paraganglioma,disease,C04,Neoplastic Process,0.11,1,2012,2012,1,0,BEFREE;HPO
54949,SDHAF2,0.604,0.692,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.12,0.5,2010,2011,2,0,BEFREE;HPO
54949,SDHAF2,0.604,0.692,C1333993,hereditary paraganglioma,disease,C16;C04,Neoplastic Process,0.34,1,2009,2017,4,0,BEFREE;GENOMICS_ENGLAND
54949,SDHAF2,0.604,0.692,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.6,1,1981,2017,12,5,CLINGEN;CLINVAR;GENOMICS_ENGLAND
54949,SDHAF2,0.604,0.692,C1866555,Glomus tympanicum paraganglioma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
54949,SDHAF2,0.604,0.692,C4274332,Hereditary pheochromocytoma and paraganglioma,disease,C04,Disease or Syndrome,0.01,1,2017,2017,1,0,BEFREE
55004,LAMTOR1,0.597,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
55004,LAMTOR1,0.597,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
55181,SMG8,0.78,0.346,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
55210,ATAD3A,0.628,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,LHGDN
55281,TMEM140,0.931,0.115,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
55294,FBXW7,0.465,0.808,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2008,2008,1,0,CTD_human
55502,HES6,0.686,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
55502,HES6,0.686,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
55534,MAML3,0.653,0.577,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
55654,TMEM127,0.638,0.615,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.4,1,2010,2020,19,0,BEFREE;GENOMICS_ENGLAND
55654,TMEM127,0.638,0.615,C1333944,Paraganglioma of head and neck,disease,C04,Neoplastic Process,0.11,1,2011,2011,1,1,BEFREE;HPO
55654,TMEM127,0.638,0.615,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.4,1,2010,2016,10,13,CLINGEN;CLINVAR
55714,TENM3,0.599,0.692,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
55872,PBK,0.541,0.769,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2014,2017,2,0,BEFREE
55907,CMAS,0.644,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
55966,AJAP1,0.722,0.192,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2006,2011,2,0,BEFREE;LHGDN
55966,AJAP1,0.722,0.192,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2006,2011,2,0,BEFREE
56994,CHPT1,0.474,0.846,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2008,2008,1,0,BEFREE
56994,CHPT1,0.474,0.846,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2008,2008,1,0,BEFREE
56994,CHPT1,0.474,0.846,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2008,2008,1,0,BEFREE
56996,SLC12A9,0.454,0.769,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
57001,SDHAF3,0.821,0.192,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,1,BEFREE
57120,GOPC,0.561,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
57142,RTN4,0.621,0.692,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,LHGDN
57212,TP73-AS1,0.599,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
57212,TP73-AS1,0.599,0.577,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
57212,TP73-AS1,0.599,0.577,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
57212,TP73-AS1,0.599,0.577,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
57212,TP73-AS1,0.599,0.577,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
57212,TP73-AS1,0.599,0.577,C0751395,Mixed Oligodendroglioma-Ependymoma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
57212,TP73-AS1,0.599,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.3,1,2010,2010,1,0,CTD_human
57212,TP73-AS1,0.599,0.577,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,2018,2018,2,0,BEFREE
57502,NLGN4X,0.686,0.423,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
57512,GPR158,0.678,0.423,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
57512,GPR158,0.678,0.423,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
57534,MIB1,0.438,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2003,2018,5,0,BEFREE;LHGDN
57534,MIB1,0.438,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
57534,MIB1,0.438,0.769,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
57534,MIB1,0.438,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2003,2009,2,0,BEFREE
57534,MIB1,0.438,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2003,2009,2,0,BEFREE
57534,MIB1,0.438,0.769,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.02,1,2007,2009,2,0,BEFREE
57534,MIB1,0.438,0.769,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,1999,1999,2,0,BEFREE
57534,MIB1,0.438,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.05,1,2003,2018,5,0,BEFREE
57670,KIAA1549,0.615,0.346,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2012,2015,2,0,BEFREE
57670,KIAA1549,0.615,0.346,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.04,0.75,2014,2019,4,0,BEFREE
57670,KIAA1549,0.615,0.346,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
57670,KIAA1549,0.615,0.346,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
57670,KIAA1549,0.615,0.346,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2012,2015,2,0,BEFREE
57670,KIAA1549,0.615,0.346,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.03,0.667,2014,2019,3,0,BEFREE
57670,KIAA1549,0.615,0.346,C2347979,Rosette-forming glioneuronal tumor of the fourth ventricle,disease,C04;C10,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
60674,GAS5,0.497,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
63827,BCAN,0.7,0.269,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,0.5,2005,2018,2,0,BEFREE
63827,BCAN,0.7,0.269,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
63827,BCAN,0.7,0.269,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
63827,BCAN,0.7,0.269,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,0.5,2005,2018,2,0,BEFREE
64083,GOLPH3,0.53,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,2017,2019,2,0,BEFREE
64098,PARVG,0.805,0.115,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2005,2005,1,0,BEFREE;LHGDN
64098,PARVG,0.805,0.115,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2005,2005,1,0,BEFREE
64098,PARVG,0.805,0.115,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2005,2005,1,0,BEFREE
64098,PARVG,0.805,0.115,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2005,2005,1,0,BEFREE
64115,VSIR,0.573,0.654,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
64147,KIF9,0.805,0.192,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
64321,SOX17,0.555,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
64321,SOX17,0.555,0.615,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
64321,SOX17,0.555,0.615,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
64321,SOX17,0.555,0.615,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
64321,SOX17,0.555,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
64321,SOX17,0.555,0.615,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
64324,NSD1,0.505,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
64324,NSD1,0.505,0.769,C0751679,"Ganglioglioma, Intracranial",disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
64324,NSD1,0.505,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
64506,CPEB1,0.638,0.538,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
65018,PINK1,0.516,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
65018,PINK1,0.516,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
65061,CDK15,0.663,0.5,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2014,2017,2,0,BEFREE
65078,RTN4R,0.595,0.692,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,0,2019,2019,1,0,BEFREE
79139,DERL1,0.576,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
79139,DERL1,0.576,0.654,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
79139,DERL1,0.576,0.654,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
79139,DERL1,0.576,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
79192,IRX1,0.695,0.538,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
79365,BHLHE41,0.623,0.577,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
79366,HMGN5,0.65,0.423,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2012,2012,1,0,CTD_human
79577,CDC73,0.543,0.615,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
79760,GEMIN7,0.861,0.115,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
79760,GEMIN7,0.861,0.115,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
79813,EHMT1,0.46,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
79813,EHMT1,0.46,0.808,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
79823,CAMKMT,0.51,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,0,2019,2019,1,0,BEFREE
79823,CAMKMT,0.51,0.808,C1708957,Mediastinal Paraganglioma,disease,,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
79947,DHDDS,0.468,0.885,C0280790,Adult Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2008,2008,1,0,BEFREE
79947,DHDDS,0.468,0.885,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2008,2008,1,0,BEFREE
79947,DHDDS,0.468,0.885,C1332943,Childhood Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2008,2008,1,0,BEFREE
80013,MINDY3,0.743,0.462,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
80013,MINDY3,0.743,0.462,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
80312,TET1,0.523,0.808,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
80315,CPEB4,0.621,0.462,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
80316,PPP1R2C,0.478,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
80316,PPP1R2C,0.478,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
80316,PPP1R2C,0.478,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
80381,CD276,0.505,0.731,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
80381,CD276,0.505,0.731,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
80381,CD276,0.505,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
81559,TRIM11,0.686,0.385,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
81621,KAZALD1,0.769,0.115,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
83478,ARHGAP24,0.456,0.808,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.06,0.833,1998,2011,6,0,BEFREE
83478,ARHGAP24,0.456,0.808,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
83478,ARHGAP24,0.456,0.808,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1998,1998,1,0,BEFREE
83478,ARHGAP24,0.456,0.808,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.06,0.833,1998,2011,6,0,BEFREE
83593,RASSF5,0.641,0.577,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
83595,SOX7,0.599,0.577,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
83858,ATAD3B,0.792,0.231,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,LHGDN
84300,UQCC2,0.705,0.462,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
84300,UQCC2,0.705,0.462,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
84312,BRMS1L,0.67,0.346,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
84504,NKX6-2,0.695,0.5,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
84504,NKX6-2,0.695,0.5,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
84654,SPZ1,0.507,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
84654,SPZ1,0.507,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
84654,SPZ1,0.507,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
84707,BEX2,0.705,0.231,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2009,2019,2,0,BEFREE
84707,BEX2,0.705,0.231,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2009,2019,2,0,BEFREE
84707,BEX2,0.705,0.231,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2009,2019,2,0,BEFREE
84707,BEX2,0.705,0.231,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2009,2019,2,0,BEFREE
84740,AFAP1-AS1,0.573,0.538,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2017,2017,1,0,CTD_human
84740,AFAP1-AS1,0.573,0.538,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2017,2017,1,0,CTD_human
84740,AFAP1-AS1,0.573,0.538,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2017,2017,1,0,CTD_human
85569,GALP,0.76,0.231,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
85569,GALP,0.76,0.231,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
85569,GALP,0.76,0.231,C4086158,Childhood Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.01,1,2006,2006,1,0,BEFREE
90780,PYGO2,0.686,0.346,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
90993,CREB3L1,0.601,0.615,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
90993,CREB3L1,0.601,0.615,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
92140,MTDH,0.491,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
92140,MTDH,0.491,0.769,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
92140,MTDH,0.491,0.769,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
92140,MTDH,0.491,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
93100,NAPRT,0.7,0.346,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
93100,NAPRT,0.7,0.346,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
112398,EGLN2,0.604,0.731,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
112398,EGLN2,0.604,0.731,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,disease,C16;C04,Disease or Syndrome,0.3,1,2015,2015,1,0,CLINGEN
112597,CYTOR,0.568,0.577,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
113130,CDCA5,0.563,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
113451,AZIN2,0.499,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
113612,CYP2U1,0.722,0.462,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.01,1,2016,2016,1,0,BEFREE
114569,MAL2,0.711,0.231,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
114569,MAL2,0.711,0.231,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
114569,MAL2,0.711,0.231,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
114569,MAL2,0.711,0.231,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
114784,CSMD2,0.695,0.269,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
114784,CSMD2,0.695,0.269,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
114960,TSGA13,0.78,0.154,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.01,1,2019,2019,1,1,BEFREE
115290,FBXO17,0.839,0.115,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
116448,OLIG1,0.722,0.423,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2004,2004,2,0,BEFREE
116448,OLIG1,0.722,0.423,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
116448,OLIG1,0.722,0.423,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2004,2004,2,0,BEFREE
120892,LRRK2,0.51,0.808,C1846865,Substantia nigra gliosis,phenotype,C23,Finding,0.1,NA,NA,NA,0,0,HPO
122664,TPPP2,0.601,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
122664,TPPP2,0.601,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
135228,CD109,0.595,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
137196,CCDC26,0.647,0.615,C0259783,mixed gliomas,disease,C04,Neoplastic Process,0.3,1,2009,2009,1,0,CTD_human
137196,CCDC26,0.647,0.615,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,1,BEFREE
140862,ISM1,0.78,0.154,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
149420,PDIK1L,0.534,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
149420,PDIK1L,0.534,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
152330,CNTN4,0.653,0.577,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
160140,C11orf65,0.67,0.462,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,CLINVAR
160622,GRASP,0.805,0.231,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
160728,SLC5A8,0.615,0.577,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
160728,SLC5A8,0.615,0.577,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2005,2005,1,0,BEFREE
161003,STOML3,0.743,0.423,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
162979,ZNF296,0.769,0.115,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
162979,ZNF296,0.769,0.115,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2003,2003,1,0,BEFREE
163732,CITED4,0.711,0.269,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
163732,CITED4,0.711,0.269,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
163732,CITED4,0.711,0.269,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
163732,CITED4,0.711,0.269,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
168400,DDX53,0.568,0.846,C0432252,Osteoporosis with pseudoglioma,disease,C16;C17;C05,Disease or Syndrome,0.01,0,2018,2018,1,0,BEFREE
203074,PRSS55,0.513,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
203074,PRSS55,0.513,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
203074,PRSS55,0.513,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
203228,C9orf72,0.496,0.769,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
219793,TBATA,0.729,0.308,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
219793,TBATA,0.729,0.308,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
219793,TBATA,0.729,0.308,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
219793,TBATA,0.729,0.308,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,0,2017,2017,1,0,BEFREE
221883,HOXA11-AS,0.61,0.423,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
223117,SEMA3D,0.678,0.423,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2015,2015,1,0,ORPHANET
283131,NEAT1,0.502,0.769,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
283446,MYO1H,0.751,0.385,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
283446,MYO1H,0.751,0.385,C0206718,Ganglioneuroblastoma,disease,C04,Neoplastic Process,0.1,NA,NA,NA,0,0,HPO
284004,HEXD,0.78,0.308,C0268274,"Gangliosidoses, GM2",disease,C16;C18;C10,Disease or Syndrome,0.02,1,2002,2014,2,0,BEFREE
284004,HEXD,0.78,0.308,C2749283,"Gm2-Gangliosidosis, Variant B1",disease,C16;C18;C10,Disease or Syndrome,0.01,1,1999,1999,1,0,BEFREE
284348,LYPD5,0.608,0.615,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
326340,ZAR1,0.674,0.269,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
326340,ZAR1,0.674,0.269,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
326340,ZAR1,0.674,0.269,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
338413,TAS2R63P,0.931,0.077,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
339896,GADL1,0.497,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
340348,TSPAN33,0.606,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
340348,TSPAN33,0.606,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
340348,TSPAN33,0.606,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
340348,TSPAN33,0.606,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
341640,FREM2,0.566,0.577,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2012,2012,1,0,BEFREE
342371,ATXN1L,0.792,0.115,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
346288,SEPTIN14,0.805,0.077,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.3,1,2013,2013,2,0,ORPHANET
346389,MACC1,0.561,0.538,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
353376,TICAM2,0.438,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
353376,TICAM2,0.438,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
404663,LINC01194,0.47,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
404663,LINC01194,0.47,0.769,C0280793,Mixed Oligodendroglioma-Astrocytoma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
406899,MIR106A,0.524,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2011,2011,1,0,BEFREE
406913,MIR126,0.447,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
406915,MIR128-1,0.695,0.346,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2018,2018,1,0,CTD_human
406915,MIR128-1,0.695,0.346,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2018,2018,1,0,CTD_human
406915,MIR128-1,0.695,0.346,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2018,2018,1,0,CTD_human
406920,MIR130B,0.547,0.808,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
406921,MIR132,0.485,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.02,1,2015,2019,2,0,BEFREE
406924,MIR134,0.542,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
406924,MIR134,0.542,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
406928,MIR137,0.513,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2008,2013,2,0,BEFREE
406928,MIR137,0.513,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2008,2013,2,0,BEFREE
406928,MIR137,0.513,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2008,2013,2,0,BEFREE
406928,MIR137,0.513,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2008,2013,2,0,BEFREE
406934,MIR142,0.48,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
406940,MIR148A,0.506,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
406952,MIR17,0.459,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
406954,MIR181A2,0.57,0.654,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
406958,MIR182,0.486,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
406959,MIR183,0.494,0.885,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
406971,MIR195,0.496,0.769,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2014,2014,1,0,CTD_human
406971,MIR195,0.496,0.769,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2014,2014,1,0,CTD_human
406971,MIR195,0.496,0.769,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2014,2014,1,0,CTD_human
406986,MIR203A,0.471,0.808,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
406988,MIR205,0.482,0.846,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
406989,MIR206,0.477,0.846,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2015,2015,1,0,CTD_human
406989,MIR206,0.477,0.846,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2015,2015,1,0,CTD_human
406989,MIR206,0.477,0.846,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2015,2015,1,0,CTD_human
406989,MIR206,0.477,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
406991,MIR21,0.363,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
406991,MIR21,0.363,0.846,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
406992,MIR210,0.46,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.05,1,2014,2019,5,0,BEFREE
406997,MIR215,0.559,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.02,1,2017,2017,2,0,BEFREE
406999,MIR217,0.543,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
406999,MIR217,0.543,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
407000,MIR218-1,0.722,0.231,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2015,2015,1,0,CTD_human
407000,MIR218-1,0.722,0.231,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2015,2015,1,0,CTD_human
407000,MIR218-1,0.722,0.231,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2015,2015,1,0,CTD_human
442459,XRCC6P5,0.579,0.769,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
442459,XRCC6P5,0.579,0.769,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2002,2002,1,0,BEFREE
442906,MIR338,0.535,0.808,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
442912,MIR367,0.59,0.654,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
494328,MIR379,0.615,0.538,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
494328,MIR379,0.615,0.538,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
494331,MIR382,0.603,0.692,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
554210,MIR429,0.544,0.731,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
554210,MIR429,0.544,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
554213,MIR449A,0.57,0.731,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
574413,MIR409,0.57,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2011,2018,2,0,BEFREE
574413,MIR409,0.57,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2011,2018,2,0,BEFREE
574452,MIR494,0.531,0.692,C3665419,intracranial glioma,disease,C04;C10,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
574480,MIR519D,0.636,0.423,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
574507,MIR504,0.67,0.462,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
642559,POU5F1P3,0.452,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
643853,TMPPE,0.821,0.192,C0085131,Gangliosidosis GM1,disease,C16;C18;C10,Disease or Syndrome,0.1,1,1994,2018,3,0,CLINVAR
643853,TMPPE,0.821,0.192,C0268271,"Gangliosidosis, Generalized GM1, Type 1 (disorder)",disease,C16;C18;C10,Disease or Syndrome,0.1,1,1994,1994,1,0,CLINVAR
643853,TMPPE,0.821,0.192,C0268272,"Gangliosidosis, Generalized GM1, Type 2",disease,C16;C18;C10,Disease or Syndrome,0.1,NA,NA,NA,0,0,CLINVAR
643853,TMPPE,0.821,0.192,C0268273,"Gangliosidosis, Generalized GM1, Type 3",disease,C16;C18;C10,Disease or Syndrome,0.1,NA,NA,NA,0,0,CLINVAR
645682,POU5F1P4,0.452,0.808,C0017075,Ganglioneuroma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
664616,MIR487B,0.67,0.423,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
664616,MIR487B,0.67,0.423,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
664709,HNRNPA1P10,0.631,0.654,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
664709,HNRNPA1P10,0.631,0.654,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2001,2001,1,0,BEFREE
724026,MIR656,0.743,0.154,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
724026,MIR656,0.743,0.154,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
100126335,MIR543,0.593,0.692,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
100128998,C20orf181,0.479,0.885,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2010,2010,1,0,BEFREE
100133941,CD24,0.472,0.769,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
100288687,DUX4,0.604,0.5,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
100288687,DUX4,0.604,0.5,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
100288687,DUX4,0.604,0.5,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
100288687,DUX4,0.604,0.5,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
100302736,TMED7-TICAM2,0.438,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
100302736,TMED7-TICAM2,0.438,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
100499467,LINC00673,0.659,0.462,C1328402,Metastatic glioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
100505887,LINC01672,0.462,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2013,2013,1,0,BEFREE
100507600,LCT-AS1,0.861,0.077,C0085758,"Aganglionosis, Colonic",disease,C16;C06,Congenital Abnormality,0.3,1,2018,2018,1,0,CTD_human
100507600,LCT-AS1,0.861,0.077,C1257840,"Aganglionosis, Rectosigmoid Colon",disease,C16;C06,Congenital Abnormality,0.3,1,2018,2018,1,0,CTD_human
100507600,LCT-AS1,0.861,0.077,C3661523,Congenital Intestinal Aganglionosis,disease,C16;C06,Disease or Syndrome,0.3,1,2018,2018,1,0,CTD_human
100529264,RAB4B-EGLN2,0.641,0.654,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
100616340,MIR4758,0.821,0.038,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2018,2018,1,0,BEFREE
100689229,H3P12,0.603,0.615,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
100689229,H3P12,0.603,0.615,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
105375355,UPK3B,0.584,0.808,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2004,2004,1,0,BEFREE
107075310,MTCO2P12,0.368,0.962,C1997217,Low grade glioma,disease,C04,Neoplastic Process,0.01,1,2017,2017,1,0,BEFREE
110806263,LOC110806263,0.464,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.06,1,2015,2018,6,0,BEFREE
110806263,LOC110806263,0.464,0.731,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2016,2016,1,0,BEFREE
110806263,LOC110806263,0.464,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2015,2018,2,0,BEFREE
110806263,LOC110806263,0.464,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.02,1,2015,2018,2,0,BEFREE
110806263,LOC110806263,0.464,0.731,C0334590,Anaplastic Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2015,2015,1,0,BEFREE
110806263,LOC110806263,0.464,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.06,1,2015,2018,6,0,BEFREE
110806263,LOC110806263,0.464,0.731,C4289580,Epithelioid glioblastoma,disease,,Neoplastic Process,0.02,1,2017,2018,2,0,BEFREE
110806263,LOC110806263,0.464,0.731,C4722099,High grade glioma,disease,C04,Neoplastic Process,0.01,1,2019,2019,1,0,BEFREE
115482684,H3P9,0.505,0.731,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
115482684,H3P9,0.505,0.731,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
115482684,H3P9,0.505,0.731,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
115482684,H3P9,0.505,0.731,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,1996,1996,1,0,BEFREE
115482685,H3P13,0.584,0.769,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
115482685,H3P13,0.584,0.769,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,1,2007,2007,1,0,BEFREE
115482696,H3P23,0.443,0.769,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
115482696,H3P23,0.443,0.769,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2008,2008,1,0,BEFREE
115482713,H3P10,0.35,0.846,C0028945,oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2004,2018,4,0,BEFREE
115482713,H3P10,0.35,0.846,C0030421,Paraganglioma,disease,C04,Neoplastic Process,0.01,1,2014,2014,1,0,BEFREE
115482713,H3P10,0.35,0.846,C0206716,Ganglioglioma,disease,C04,Neoplastic Process,0.01,0,2003,2003,1,0,BEFREE
115482713,H3P10,0.35,0.846,C0206726,gliosarcoma,disease,C04,Neoplastic Process,0.01,1,2000,2000,1,0,BEFREE
115482713,H3P10,0.35,0.846,C0279070,Adult Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
115482713,H3P10,0.35,0.846,C0280475,Childhood Oligodendroglioma,disease,C04,Neoplastic Process,0.01,1,2009,2009,1,0,BEFREE
115482713,H3P10,0.35,0.846,C0751396,Well Differentiated Oligodendroglioma,disease,C04,Neoplastic Process,0.04,1,2004,2018,4,0,BEFREE
115482713,H3P10,0.35,0.846,C1332969,Childhood Ganglioglioma,disease,C04,Neoplastic Process,0.01,0,2003,2003,1,0,BEFREE